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SUMMARY 
 
Early events in virus infections critically depend on host membrane dynamics involving both proteins and 
lipids. How lipids tune the viral life cycle has remained largely elusive, however. Here, we used adenovirus 
as a model to study the role of lipid metabolism in viral invasion. Adenovirus is a non-enveloped virus that 
relies on its capsid proteins to hijack host machineries and overcome the cellular membrane barrier. 
Incoming adenoviruses engage with the receptor CAR and the co-receptors αvβ3/5 integrins to elicit their 
internalization. Concomitantly with binding and endocytosis, the viral capsid undergoes a stepwise 
uncoating program. These early events are crucial for infection and lead to the exposure of membrane 
active internal viral capsid proteins, such as protein VI. Protein VI is the membrane lytic factor that 
mediates the escape of the virus from endosomes to the cytosol. Yet, how the 90 nm capsid penetrates the 
endosomal membrane remains poorly understood. 
Lipid profiling of infected cells revealed a rapid and selective enrichment of ceramides during adenovirus 
entry. This change in the lipid composition was required for infection and was mediated by the enzyme acid 
sphingomyelinase (ASMase). ASMase constitutively generates ceramide from sphingomyelin in lysosomes. 
Interestingly, inhibition of ASMase activity affected multiple steps of viral invasion.  Adenovirus endocytosis 
was delayed, association of protein VI with the cell membrane was impaired, and the escape of viruses to 
the cytosol was reduced. Remarkably, in vitro experiments with liposomes showed that protein VI 
preferentially associated with and ruptured membranes containing ceramides. To address how a lysosomal 
enzyme could regulate events at the plasma membrane, we tracked the sub-cellular localization of ASMase. 
We found that ASMase was released from lysosomes to the extracellular space within the first minutes 
after virus binding in a process that has been previously described as lysosomal exocytosis. This is a cellular 
response regulated by calcium (Ca2+) to repair small lesions of the plasma membrane. Consistently, we 
observed a transient influx of extracellular Ca2+ into the cytosol. Moreover, we observed a simultaneous 
influx of membrane-impermeable propidium iodide across the plasma membrane, suggesting that the 
plasma membrane of virus infected cells contained small, temporary lesions within the first few minutes of 
infection. Further experiments involving fluorescence microscopy and mutant viruses indicated that protein 
VI was partially released already at the cell surface and mediated plasma membrane permeabilization. 
We propose a model where virus uncoating at the cell surface leads to a partial release of protein VI from 
the inside of the virus. This leads to the formation of transient, and rapidly resolved membrane lesions. 
These lesions serve as a portal for the influx of extracellular calcium, which triggers lysosomal exocytosis 
and delivers ASMase to the plasma membrane. ASMase increases surface ceramide to enhance virus 
endocytosis and VI exposure. In endosomes, VI interacts with ceramide-enriched membranes to enhance 
endosomal lysis and virus escape into the cytosol. Together, this study shows how an incoming, non-
enveloped virus modulates lipid metabolism for efficient invasion and productive infection. 
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ZUSAMMENFASSUNG 
 
Die ersten Schritte einer Virusinfektion hängen von der Dynamik der Zellmembran ab. Wie Lipide den 
viralen Lebenszyklus beeinflussen ist weitgehend ungeklärt. In dieser Studie benutzten wir Adenovirus als 
Modell um die Rolle des Lipid Metabolismus in der viralen Invasion zu studieren. Adenoviren sind nicht-
behüllte Viren, das heisst sie sind nicht von einer Membran umschlossen, und sind deshalb auf ihr virales 
Kapsid angewiesen um zelluläre Maschinerien zu beschlagnahmen und die Zellmembran zu überwinden. 
Eintretende Adenoviren binden an den Rezeptor CAR und an den Co-Rezeptor  αvβ3/5 Integrin um ihre 
Aufnahme in die Zelle zu initiieren. Gleichzeitig mit der Bindung an einen Rezeptor und der Aufnahme in die 
Zelle begeht das Virus ein Enthüllungsprogramm. Dies führt dazu dass das Kapsid-interne virale Proteine, 
wie z.B. Protein VI exponiert werden. Protein VI ist ein Membran-lytischer Faktor, welcher das Austreten 
der Viren aus einem Endosom ins Zytoplasma vermittelt. Die Frage wie das Kapsid mit einem Durchmesser 
von 90 nm die endosomale Membran durchbricht bleibt weitgehend offen.  
Durch eine Profilierung der Lipide in infizierten Zellen fanden wir heraus, dass sich während der Infektion 
Ceramide schnell anreichern. Diese Änderung in der Lipid komposition war notwendig für eine Infektion 
und wurde durch das Enzym Acid Sphingomyelinase (ASMase) vermittelt. ASMase generiert Ceramide aus 
Sphingomyelin konstitutiv in Endosomen. Interessanterweise beeinflusste eine Inhibition von ASMase 
verschiedene Schritte der viralen Invasion. Die Endozytose der Adenoviren war verlangsamt, die Assoziation 
von dem Protein VI mit der Zellmembran war beeinträchtigt und das Austreten des Virus ins Zytosol war 
vermindert. Bemerkenswerterweise zeigten in vitro Experimente dass Protein VI bevorzugt Membrane 
bricht die Ceramide enthalten. Um herauszufinden wie ein lysosomales Enzym die viralen Ereignisse an der 
Plasmamembran regulieren kann, haben wie die sub-zelluläre Lokalisation von ASMase verfolgt. 
Wir fanden dass die ASMase innerhalb von wenigen Minuten nach der Bindung des Virus von Lysosomen in 
den extrazellulären Raum geschleust wurde. Dieser Prozess wurde als lysosomale Exozytose beschrieben, 
als eine Kalzium (Ca2+) abhängige zelluläre Antwort um kleine Läsionen in der Plasmamembran zu 
reparieren. Konsistenterweise beobachteten wir dass extrazelluläres Ca2+ in das Zytosol aufgenommen 
wurde und gleichzeitig auch grössere Moleküle wie Propidium Iodid was darauf hindeutete, dass das Virus 
in den ersten Minuten nach der Bindung an den Rezeptor kleine, temporäre Läsionen in der 
Plasmamembran induzierte. Nachfolgende Experimente mittels Fluoreszenzmikroskopie und 
Virusmutanten zeigten dass das Protein VI schon teilweise an der Zelloberfläche vom Viruskapsid entlassen 
wurde was zu einer Permeabilisierung der Plasmamembran führte. 
Wir schlagen ein Modell vor wo die Virusenthüllung an der Zelloberfläche zu einer partiellen Entlassung von 
Protein VI aus dem Viruskapsid führt. Dies führt zu transienten und schnell resolvierten Membranläsionen 
welche als Portal für das Eintreten von extrazellulärem Kalzium dienen. Dies löst eine lysosomale Exozytose 
aus wodurch ASMase an die Plasmamembran gelangt. ASMase erhöht die Konzentration von Ceramid an 
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der Zelloberfläche und beschleunigt  die Endozytose des Virus. Protein VI interagiert in Endosomen mit 
Ceramid-angereicherten Membranen was deren Lyse und das Austreten des Virus ins Zytosol beschleunigt. 
Zusammengefasst zeigt diese Studie dass eintretende, nicht-behüllte Viren den Metabolismus von Lipiden 
modulieren um die Zelle zu infizieren. 
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INTRODUCTION 
 
1. EARLY EVENTS OF VIRUS INFECTION 
Viral diseases have dramatic repercussions on humanitarian, economic and political aspects of our society. 
Advances on vaccines and antiviral research greatly contributed to the control, prevention, or even 
eradication of viral disease. Nonetheless, there is a need to further improve our knowledge on virus 
infections as viral diseases continue to threat global health. Since viruses require their host cells for 
infection and disease development, a better understanding of the biology of virus-host interactions may 
offer new perspectives for the treatment of viral disease. 
The first point of contact between a virus and the host cell is the plasma membrane (PM). The PM 
constitutes a physical barrier against viral invasions, but is also a platform for complex and dynamic 
interactions. Incoming viruses engage with surface cellular receptors and signaling factors. They trigger a 
cascade of events that prime both cell metabolism and virus structures for infection. 
 
 
Fig. 1: EM micrographs of early steps of adenovirus entry. Binding (a), invagination (b) and      
 endosomal localization of HAdV-C2 in HeLa cells. Scale bar: 100 nm (Meier et al., 2002). 
 
It is becoming increasingly clear that early infection events determine whether the virus will successfully 
spread or be neutralized. Recent studies highlight the importance of lipid metabolism and membrane 
dynamics during viral infections. This work focuses on the interplay between viruses and host cell lipids 
during virus entry. 
1.1 MEMBRANE PENETRATION OF NON ENVELOPED VIRUSES 
A major challenge for viruses is to transiently destabilize and cross the host membranes without 
compromising cell viability. For example, lysis of the PM would be detrimental to the cell and eventually 
lead to cell death before the invading viruses would have replicated. To avoid PM lysis, most viruses induce 
their own internalization by receptor-mediated endocytosis and accomplish the actual step of penetration 
from intracellular compartments. This strategy limits cellular damage to specific intracellular compartments 
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and ensures clearance of viral components from the cell surface where they are exposed to the immune 
system. While it is well established that enveloped viruses carry fusion machineries to merge their own 
envelope with cellular membranes, it remains poorly understood how non-enveloped viruses cross the host 
lipid bilayer.  
Capsids of non-enveloped viruses are highly ordered and tightly packed protein structures that enclose and 
protect the viral genome. A key feature that determines virus infectivity is the capsid meta-stability. On the 
one hand, capsids must stay intact and protect the viral genome from environmental and physiological 
insults, and on the other hand they need to disassemble in the host cell to activate their dormant genome. 
Throughout the binding and entry process, capsids undergo finely controlled structural rearrangements 
dictated by sequential interactions with cellular cues (Suomalainen and Greber, 2013). Conformational 
changes that prime the capsid for uncoating can occur at the early stage of receptor binding. Additional 
mechanical or chemical cues drive a spatiotemporally coordinated exposure of membrane interacting 
domains (Bilkova et al., 2014; Suomalainen and Greber, 2013). In general, membrane-interacting domains 
are either hydrophobic or amphipathic and sometimes require proteolytic processing to become 
membrane-active. They induce membrane leakage or rupture, locally modify the lipid composition, or 
interact with cellular factors that mediate membrane translocation (Moyer and Nemerow, 2011). 
While virus entry and replication strongly depend on host factors, the actual membrane penetration step is 
thought to predominantly rely on viral factors. A role of the host lipids in these processes is poorly 
understood.  
   
1.1.2 Non receptor-mediated membrane permeabilization 
Particular proteins capable of perturbing membrane integrity have evolved across kingdoms. An example 
are bacterial pore-forming toxins that perform a selective, receptor-mediated membrane perforation. 
Generally these toxins bind to a cellular target, a specific lipid, a sugar moiety or a surface protein, and 
oligomerize into a pore-structure that inserts into membranes. These pores allow translocation of bacterial 
components into the target cell or mediate efflux of cytosolic components, thereby compromising the cell 
integrity (Bischofberger et al., 2012; Los et al., 2013). 
Other peptides are capable of non-receptor mediated membrane perforation and are therefore bioactive 
against a wide range of targets. Among these, antimicrobial peptides (AMPs) and components of the 
complement system participate in host defense against a broad spectrum of pathogens (Andersson et al., 
2004; Brogden, 2005). Also, cell penetrating peptides (CPPs) can translocate across several biological 
membranes (Vivès et al., 2008). Finally, amyloid peptides promote the pathogenesis of several diseases, 
including Alzheimer disease, by permeabilizing cellular membranes (Hebda et al., 2009) without receptor 
recognition.  
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Lessons from the widely studied pore forming process by AMPs might help to understand how non-
enveloped viruses penetrate membranes. 
Common structural features of several AMPs, amyloid peptides, CPPs as well as some viral lytic factors are 
their amphipathic nature and the short size, usually less than 50 amino acids (Last et al., 2013; Moyer and 
Nemerow, 2011). These proteins are soluble in water and generally have a disordered structure (Marion et 
al., 1988; Williamson et al., 2009) until they reach proximity of the lipophilic environment of cell 
membranes. This promotes their folding into a secondary structure with amphipathic properties (Shai, 
1999). Amphipathic structures increase their energetic stability in a way that the polar side chain remains 
exposed to the solvent, while the non-polar region partitions between the lipid head groups into the 
membrane acyl core (Huang, 2006; Marion et al., 1988). The initial association of amphipathic helices with 
membranes is thought to occur laterally, with the helix oriented in a parallel fashion to the lipid bilayer. 
This was shown for the AMP cecropin A (Marassi et al., 1999) and the amyloid peptide α-synuclein 
(Apostolidou et al., 2008; Marion et al., 1988). Afterwards peptides can also insert into the membrane and 
form a transmembrane domain (Ding and Chen, 2012). Generally, accumulation of these peptides leads to 
thinning of the bilayer in a dose-dependent manner (Chen et al., 2003). When a critical peptide/membrane 
ratio is reached, peptides finally insert into the bilayer and trigger a localized collapse of the membrane 
(Chen et al., 2002; Shai, 1999). Various modalities of permeabilization have been proposed and mostly 
depend on local protein concentration, membrane affinity and protein-protein affinity. Mechanisms include 
formation of a lipid-peptide toroidal pore, a peptide-peptide barrel-stave inserted into the bilayer, or 
interference with the bilayer integrity similar to detergents. In the following section, well-characterized 
models of membrane poration are discussed. 
 
The carpet model 
The carpet model incorporates both short-lived poration and membrane solubilization events. This model 
was first described as mode of action for the porcine intestinal AMP cecropin P1 (Gazit et al., 1995). 
Cecropins are 31-39 aa peptides that fold into an amphipathic alpha-helix in presence of lipid bilayers 
(Hultmark et al., 1980). It contains several cationic amino acids that bind with high affinity to the head 
groups of phospholipids in bacterial membranes, which are negatively charged. Cecropin A binds to 
membranes in a parallel fashion (Marassi et al., 1999). Such binding expands the surface area of the outer 
leaflet, promotes the thinning of the bilayer (Chen et al., 2003; He et al., 1996; Heller et al., 1997; Lee et al., 
2004; Mecke et al., 2005) and induces a positive membrane curvature (Hallock et al., 2003; Matsuzaki et al., 
1998a). While the outer leaflet of the membrane is strongly modified, the lipid packaging of the inner 
leaflet remains intact. This mismatch likely favors peptide insertion or aggregation (Hallock et al., 2003). 
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Fig. 2: Schematic representation of the insertion of an amphipathic alpha-helical peptide into a 
lipid bilayer and the subsequent induction of positive membrane curvature. (McMahon and 
Gallop, 2005) 
 
Depending on the protein to lipid ratio, two different scenarios are possible: the sinking raft model or the 
detergent model. In the sinking raft model, single peptides or small aggregates intercalate between lipids 
and translocate across the bilayer. The translocation process disturbs membrane integrity and permits 
leakage events. Immediately following translocation the bilayer barrier is resealed, giving rise to short lived 
membrane openings (Pokorny and Almeida, 2004). When a critical peptide concentration is reached, 
peptides can act like detergents and partially solubilize membranes (Hristova et al., 1997). 
 
 
Fig. 3: Schematic representation of the carpet model. (A) The hydrophobic side of peptides (red) 
associates in parallel to membranes. After a critical concentration is reached, the membrane 
is transiently permeabilized (B) or disrupted (C). (Shai, 2002) 
 
The toroidal and barrel-stave pore models 
The toroidal and barrel-stave models explain the formation of long-lived pores. In the toroidal-pore model, 
the association of AMPs with the membrane induces a back-bending  of lipids until the outer and inner 
leaflet are connected and the peptides perpendicularly intercalate between phospholipids (Hallock et al., 
2003; Huang, 2000; Ludtke et al., 1996; Matsuzaki et al., 1996; Yang et al., 2001). Thereby, lipids facilitate 
the poration process as they cooperate with peptides that are too short to span the lipid bilayer. 
In the barrel-stave pore model peptides are required to associate into a channel-like structure and to be 
sufficiently long to traverse the lipid bilayer (Christensen et al., 1988; Juvvadi et al., 1996; Kagan et al., 
1990; Porcelli et al., 2004; Westerhoff et al., 1989). A well-characterized example is alamethicin, a 20 amino 
acids hydrophobic peptide from the fungus Trichodermaveridae. Monomers of alamethicin aggregate into 
the membrane and form voltage-gated channels (Barranger-Mathys and Cafiso, 1994; Cafiso, 1994; Huang, 
2000; Mueller and Rudin, 1968). Alamethicin pores consist of 8 or 9 α-helices per channel and have a 
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diameter from 18 to 26 Å depending on the lipid composition of the surrounding membrane and the 
hydration degree (Heller et al., 1997; Rizzo et al., 1987). 
 
Fig. 4: Schematic representation of a toroidal pore (A) and a barrel-stave pore (B). In both cases,      
the lipophilic side of the lipids faces the hydrophobic core of the bilayer. In (A) peptides and 
lipids cooperate to form a pore, whereas in (B) peptides assemble into a channel structure. 
   (Shai, 2002) 
These models are supported by a large number of studies and are widely accepted. However, several 
studies on AMPs suggest a more complex landscape of permeabilization modalities. For example, the 
component of bee venom melittin preferentially forms pores in vesicles composed of neutral lipids (Lee et 
al., 2008) but acts via detergent-like mechanism in presence of anionic lipids (Ladokhin and White, 2001). 
Similarly, magainin 2 switches between two modes of action depending on the protein/lipid ratio: at low 
concentration it provokes toroidal pores (Ludtke et al., 1996), while at high concentrations it generates 
chaotic pores (Gregory et al., 2009). Also, the cholesterol content of membranes influences insertion and 
bioactivity of several AMPs (Mason et al., 2007; Nicol et al., 1996; Won et al., 2012). These findings 
underline that the modality of membrane perforation does not exclusively depend on the intrinsic 
properties of the peptides but also on the biophysical properties of the target membrane. This topic is 
further considered in the discussion. 
 
1.1.3 Membrane-active viral factors 
Membrane active factors of non-enveloped viruses generally contain either amphipathic alpha-helical 
domains or hydrophobic residues, are myristoylated or even encode a lipid modifying function (Moyer and 
Nemerow, 2011). The following section describes mechanisms of penetration by selected non-enveloped 
viruses with a focus on the membrane rupture step and the role of cellular lipids. 
An amphipathic α-helical lytic factor sensitive to lipids: gamma of flock house virus 
Flock house virus (FHV) is a positive-sense RNA virus of about 30 nm capable to infect plants, insects, yeast 
and mammalian cells. To date, surface receptors and the uptake mechanism of this virus are not known. 
The formation of the viral capsid begins with the self association of a single structural protein, protein 
alpha, followed by enclosure of the RNA genome. Capsid maturation proceeds with autoproteolytic 
cleavage of protein alpha into the structural protein beta and the membrane-active peptide gamma. In 
A B 
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intact viruses peptide gamma is located whithin the capsid, and is only occasionally exposed to the surface 
during capsid breathing (Bothner et al., 1998). During endocytosis FHV interacts with surface receptors 
(Walukiewicz et al., 2006) and is exposed to a low pH in endosomes (Banerjee and Johnson, 2008). The 
combination of these events elicits conformational changes leading to the externalization of peptide 
gamma. 
Gamma is composed of 44 aa, of which the first 21 residues form an amphipathic alpha helical domain, 
gamma-1 (Schneemann et al., 1992; Zlotnick et al., 1994). Theoretically, the length of gamma-1 is sufficient 
to span the endosomal membrane. (The thickness of a lipid bilayer is 6 nm, where 3 nm are hydrophobic 
core and 2x1.5 nm hydrophilic head. A typical alpha-helix has 3.6 residues per turn, and 0.54 nm is the 
vertical distance between consecutive helical turns. The length of a 21 aa alpha-helix is 3.15 nm.) 
Structural studies with intact viruses showed that gamma peptides assemble into pentameric bundles of 
amphipathic alpha-helices and  form a channel-like structure (Cheng et al., 1994). This suggested that FHV 
can form pores in the endosomal membrane, through which the RNA genome might pass into the cytosol. 
However, studies with a synthetic peptide encompassing the first 21 aa of gamma showed that these alpha-
helical peptides associate with membranes in a parallel fashion (Janshoff et al., 1999). Also, viral infectivity 
is not affected by the deletion of one or two turns of the helix (Banerjee and Johnson, 2008). Together, 
these data exclude the hypothesis of pore production but rather support the concept that gamma 
destabilizes membranes by modifying their lipid packaging. The lipid composition of the membrane is in 
turn proposed to modulate membrane lysis. Maia and collaborators performed liposome leakage assays 
with synthetic gamma-1 (Maia et al., 2006). They observed that increasing the cholesterol content of a 
model lipid bilayer from 0.2 mol% (PC:PE:SM:Cho 1:1:1:0.2) to 1.5 mol% (PC:PE:SM:Cho 1:1:1:1.5) strongly 
reduced the capacity of gamma-1 to permeabilize membranes (Fig. 6; Maia et al., 2006). How cholesterol 
metabolism affects FHV in vivo remains obscure, however these results highlight the importance of 
membrane lipid composition for efficient membrane penetration. 
 
 
Fig. 6: Liposome leakage mediated by the gamma peptide. Gamma was exposed to vesicles 
containing PC/PE/SPM/Cho (1:1:1:1.5) at pH 6.5 (green line) and pH 4.0 (purple line) or to 
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vesicles composed of PC/PE/SPM/Cho (1:1:1:0.2) at pH 6.5 (red line) and pH 4.0 (blue 
line). (Maia et al., 2006) 
 
Membrane tension as a trigger for endosomal rupture? The example of Rotavirus 
Rotavirus is a major cause of dehydrating childhood diarrhea and accounts for over 400'000 deaths 
annually (Parashar et al., 2003). Rotaviruses consist of three layers of proteins that form an icosahedral 
shell and enclose the double-stranded RNA genome (Fig. 7; Li et al., 2009; Prasad et al., 1988; Settembre et 
al., 2011; Yeager et al., 1990). Most Rotaviruses bind to surface glycans (Haselhorst et al., 2009; Hu et al., 
2012) via the outer shell proteins VP7 and VP4. Cell attachment depends on the presence of extracellular 
Ca2+ (Dormitzer et al., 2000). VP4 dictates which endocytic route will be taken (Díaz-Salinas et al., 2014). 
Strikingly, VP4 cleavage by trypsin in the gut is essential for infection (Estes et al., 1981). The result of VP4 
cleavage is the generation of the two fragments VP8* and VP5*. VP5* first mediates the interaction with 
entry cofactors and in a second step the lysis of endosomal membranes (Lopez and Arias, 2006).  
 
 
 
 
Fig. 7: Multilayered structure of a rotavirus particle, based on cryo-EM three-dimensional image      
reconstructions (Chen et al., 2009; Li et al., 2009). Color coding for the structural proteins is 
indicated by labels. (Trask et al., 2010) 
 
 
Endocytosis occurs very rapidly and virions reside in internalized vesicles no longer than 1-3 min. Notably, 
the vesicles from which virions escape are very small. They have a minimal diameter required to enclose 
viruses (Abdelhakim et al., 2014). Loss of calcium in these vesicles triggers the dissociation of VP7 
(Settembre et al., 2011). As a consequence, VP5*-VP8* is de-capped and VP5* undergoes conformational 
changes that expose three hydrophobic domains at the terminal tip of a beta barrel (Denisova et al., 1999; 
Graham and Estes, 1980). The extended hydrophobic apex is proposed to bind to the endosomal 
membrane before folding-back into a more stable conformation (Fig. 8, Dormitzer et al., 2004). The "back-
folding" likely provides the free energy required for membrane rupture.  
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Fig. 8: Schematic representation of the VP5* intermediate interacting with the limiting membrane, 
its "back-folding"  into a stable structure and the resulting membrane extension. 
(Abdelhakim et al., 2014) 
 
How does the rupture occur? Cells respond to local stretching of the PM by either increasing pulling 
tensions through the cytoskeleton, by providing further membrane reservoirs through exocytosis, or by 
regulating ion channels (Groulx et al., 2006). However, these compensatory mechanisms hardly apply to 
endocytic vesicles, rendering their membrane more prone to stretching-mediated rupture. In fact, a 3% 
increase in surface area is the lowest threshold for stretching-mediated membrane rupture (Abdelhakim et 
al., 2014). Binding of a single VP5* already increases the surface of the limiting vesicle by 0.5%. As such, 
even an incomplete processing of the 60 copies of VP5* would be sufficient for membrane rupture. Of 
note, viruses found in bigger vesicles, such as Rab5-positive endosomes of about 200 nm diameter, are 
non-infectious (Abdelhakim et al., 2014).  
 
Entry from endosomes or PM? The case of Reovirus 
Reoviruses infect most mammalian species, albeit with low pathogenicity in humans (Ouattara et al., 2011). 
The primary site of infection is the gastrointestinal tract, where reovirus uses JAM-A and sialic acid as 
receptors (Barton et al., 2001a; Barton et al., 2001b; Forrest et al., 2003; Reiss et al., 2012). In rare cases, 
the primary infection is followed by viremia and results in infections of the central nervous system. The 
neurotropism of reoviruses relies in the engagement with Nogo receptor 1 (Konopka-Anstadt et al., 2014).  
Reoviruses have a double-stranded RNA genome enclosed in two concentric capsid layers, with the outer 
layer being constituted by σ3 (Nibert, 1998). Virions are internalized by clathrin mediated endocytosis and 
delivered to late endosomes  (Maginnis et al., 2006; Mainou and Dermody, 2012; Mainou et al., 2013). 
There, virions are subjected to a stepwise, acid-dependent proteolytic processing by cathepsins B and L. 
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These disassembly steps produce intermediate subviral particles, named ISVPs. ISVPs are characterized by 
the loss of the outer σ3 shell, the autocatalytic cleavage of μ1 and the extrusion of μ1N (Ebert et al., 2002). 
 
Fig. 9: Representation of a reovirus mature particle and an ISVP. (Konopka-Anstadt et al., 2014) 
 
μ1N is myristoylated and contains a region of alternating hydrophobic residues, features that are essential 
for virus escape (Agosto et al., 2007; Drayna and Fields, 1982; Hooper and Fields, 1996; Zhang et al., 2009). 
Myristoylated μ1N generates pores of about 5 nm diameter in erythrocytes and liposomes (Agosto et al., 
2006; Ivanovic et al., 2008; Zhang et al., 2009). Yet, such openings are not sufficient for capsid translocation 
considering that the core of reoviruses which ultimately reaches the cytosol has a diameter of about 75 nm 
(Agosto et al., 2006). Instead, small pores might be the initial trigger of osmotic swelling or engagement 
with cellular factors or other events required for efficient membrane penetration in a second moment 
(Ivanovic et al., 2007). Another possibility proposed by Zhang and collaborators is that a 70 nm pore is 
generated per endosome. The full release of μ1N would provide 600 copies contained in one endosome of 
about 250 nm in diameter, for a final peptide concentration of approximately 0.1 mM. This potentially 
favors the assembly of 250 μ1N hairpins, which would be sufficient to generate a β-barrel pore of 70 nm in 
diameter (Zhang 2009). 
Interestingly, both mature reovirus particles and ISVPs are infectious (Chandran and Nibert, 1998; 
Chandran et al., 1999). An intriguing question is whether ISVPs, which have the appropriate conformation 
required for membrane permeation, enter cells via receptor mediated endocytosis or penetrate directly 
from the PM. Like intact virions, ISVPs bind to JAM-A, but instead of depending on endocytosis they are 
thought to enter from the PM (Barton et al., 2001b; Borsa et al., 1979; Boulant et al., 2013). Indeed, ISVPs 
can directly damage membranes (Chandran et al., 2002; Coffey et al., 1998). Studies by Schulz and 
colleagues addressed this topic and proposed that ISVPs enter cells via a caveolar pathway. Yet, they did 
not formally exclude the possibility of direct membrane penetration. All in all, these reports suggest that 
although ISVPs have the potential to directly lyse the PM, the preferred entry pathway seems to be 
receptor-mediated endocytosis (Schulz et al., 2012). Besides the reasons discussed in the previous section, 
one possibility is that ISVPs are endocytosed before the critical μ1N/lipid ratio for lysis is reached. Another 
reason might be that additional intracellular factors required for efficient escape are exclusively recruited 
from endosomes. 
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Escape without membrane insertion of viral factors: the unique (?) case of parvoviruses 
Parvoviruses are among the smallest viruses with a capsid diameter ranging from 18 to 26 nm, enclosing a 
single stranded DNA genome. Parvoviruses infect vertebrates as well as insects using a variety of receptors 
to induce their uptake, mostly by clathrin-mediated endocytosis (Bilkova et al., 2014; Mani et al., 2006; Ros 
et al., 2006). 
Parvovirus capsids are sensitive to pH changes (Bartlett et al., 2000; Parker and Parrish, 2000; Sonntag et 
al., 2006; Suikkanen et al., 2003), endosomal proteases (Farr et al., 2006; Mani et al., 2006) and lipid 
composition of the surrounding membrane (Karttunen et al., 2008). Interestingly, Karttunen and colleagues 
described that the presence of either sphingomyelin or phosphatidylserine in membranes was sufficient to 
induce capsid rearrangements. A crucial event during rearrangement of the capsid is the exposure of the 
parvovirus escape factor, VP1. The N-terminus of the minor coat protein VP1 has a conserved domain with 
Ca2+-dependent phospholipase A2 activity (PLA2) (Dorsch et al., 2002; Filippone et al., 2008; Girod et al., 
2002; Vihinen-Ranta et al., 1997). 
Mutations that abrogate the enzymatic activity of the PLA2 domain lead to a strong decrease in infection of 
minute virus of mice (MVM), adeno-associated virus 2, and parvovirus B19  (Farr et al., 2005; Filippone et 
al., 2008; Stahnke et al., 2011; Zádori et al., 2001). Interestingly, such mutations do not affect capsid 
assembly, binding and entry, but impair the delivery of the viral genome to the nucleus. 
For MVM, defects in PLA2 are rescued by inducing endosomal lysis with either polyethylenimine treatment 
or co-infection with adenovirus (Farr et al., 2005; Filippone et al., 2008; Stahnke et al., 2011; Zádori et al., 
2001), suggesting a specific role for PLA2 in membrane permeabilization. PLA2 catalyses the cleavage of 
phospholipids into lyso-phospholipids and arachidonic acid. Transformation of phosphatidylcholine, a 
cylindrical lipid into lyso-phosphatidic acid, an inverted cone-shaped lipid, implies a local modification of 
membrane curvature. Topologically, this change induces the budding of the limiting membrane towards the 
endosomal lumen (Shin et al., 2012). Endosomal escape of parvoviruses does not support the co-delivery to 
the cytosol of other molecules of varying size like FITC-dextran (10 kDa) or sarcin (Parker and Parrish, 2000; 
Suikkanen et al., 2003). Assuming that uptake markers and viruses are contained in the same endosomal 
vesicles, these observations indicate that membrane destabilization by PLA2 is small, temporary and rapidly 
reverted. Of note, Karttunen and collaborators showed that neither SM nor PS affected the enzymatic 
activity of PLA2 (Karttunen et al., 2008). Together, these observations propose multiple roles for lipids in 
parvovirus penetration. Firstly, lipids induce rearrangements in the viral capsid, and secondly they support 
the escape of the virus into the cytosol. Notably, local rearrangements of lipids in terms of membrane 
shaping are sufficient to destabilize endosomes. Thus, the insertion of viral components into confining 
membranes is not a pre-requisite for viral penetration, but might rather be part of a more general 
endosomal destabilization strategy. 
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2. MEMBRANE DYNAMICS AND SPHINGOLIPID METABOLISM 
2.1 Ceramide 
Structure, metabolism and compartmentalization 
Ceramide was discovered as a structural component of cellular membranes and later emerged as a 
bioactive lipid. Ceramide is involved in the regulation of cellular processes, such as stress response, 
apoptosis, cell senescence and growth arrest (Błachnio-Zabielska et al., 2008; Dickson, 2008; Dobrzyń and 
Górski, 2002; Goldkorn and Filosto, 2010; Guillas et al., 2003; Hannun, 1996; Nikolova-Karakashian and 
Rozenova, 2010; Pattingre et al., 2009; Stiban et al., 2010). 
 
 
Fig. 10: ceramide C16 (natural). 
Ceramide is composed of a sphingoid base connected to a fatty acyl via an amide bond and has an 
hydroxyl-group exposed on the head. While the sphingoid base is mostly sphingosine, the fatty acyl chains 
vary in length, saturation and hydroxylation. Ceramide metabolism comprises at least 28 enzymes that 
generate over 200 structurally distinct ceramides in a combinatorial fashion (Hannun and Obeid, 2011). 
Most mammalian ceramides have long (C16-20) or very long acyl chains (C22-24), with a few exceptions 
such as C26-36, which is selectively found in keratinocytes and male germ cells (Sandhoff, 2010). The 
biological implications of the high variety in ceramide species remain poorly understood (Castro et al., 
2014). It is notable, however, that the ceramide metabolism is highly compartmentalized (Ohanian and 
Ohanian, 2001). Natural ceramides are highly hydrophobic and insoluble in water. They preferentially 
reside in the membrane where they have been generated. The sub-cellular location of the ceramide 
generating enzymes therefore is an important factor for the bioactive function of ceramides, for example as 
cells respond to specific stimuli (Hannun and Obeid, 2011). 
 
Ceramide de novo synthesis occurs in the ER (Fig. 11). The first, rate limiting step is the condensation of 
serine and palmitoylCoA by serine-palmitoyltransferase (Bartke and Hannun, 2009; Carpinteiro et al., 2008). 
The acyl group is added by ceramide synthase, that combines the metabolite sphinganine with fatty-
acylCoA. Mammals have 6 isoforms of ceramide synthase and each displays selectivity for acylCoA of 
different lengths (Mullen et al., 2012). Thus, ceramide synthases dictate the synthesis of ceramides with 
different chain lengths. From the ER, ceramide is transported to the Golgi either via ceramide transfer 
proteins (CERT) or vesicular trafficking. In the Golgi, where ceramide is a building block for the synthesis of 
either sphingomyelin or glycosphigolipids (Fig. 12 a). 
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Fig. 11:  schematic representation of the ceramide metabolic network. Ceramide is produced 
de novo (violet), or from hydrolysis of sphingomyelin (blue) or cerebrosides (green). 
Ceramide itself is a substrate for the synthesis of sphingomyelin and glycolipids or the 
phosphorilation by ceramide kinase (CK) (Sugiura et al., 2002). Ceramides are 
metabolized by ceramidases (CDase) (el Bawab et al., 2002; Mao et al., 2001; Strelow 
et al., 2000) to produce sphingosine. Sphingosine is the precursor sphingosine-1-
phosphate (S1P), a the last metabolite before final breakdown of sphingolipids into 
ethanolamine-1-phosphate and C16-fatty-aldehyde by S1P lyase. C1PP, ceramide-1-
phosphate phosphatase; CRS, cerebrosidase; CK, ceramide kinase; CS, ceramide 
synthase; DAG, diacylglycerol; DES, dihydroceramidedesaturase; GCS, 
glucosylceramide synthase; PC, phosphatidylcholine; S1PP, S1P phosphatase, SMS, 
sphingomyelin synthase; SMase, sphingomyelinase; SPT, serine-palmitoyltransferase. 
(Ogretmen and Hannun, 2004) 
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Besides de novo synthesis, ceramide can be generated via the degradation of complex sphingolipids in an 
ensemble of reactions named salvage pathway. The salvage pathway involves sphingomyelin hydrolysis and 
breakdown of sphingosine and gluco- or galactosylceramide. Among these, the most frequent and best 
characterized step is sphingomyelin hydrolysis by acid and neutral sphingomyelinases. Thereby, ceramides 
are selectively generated at the plasma membrane (Fig. 12 e), in mitochondrial membranes (Fig. 12 b) or in 
membranes of the endolysosomal system (Fig. 12 d). Further details are described in the section 'Acid 
sphingomyelinase'. 
 
 
Fig. 12: Selected biological functions of compartmentalized ceramides.  Ceramide is generated 
de novo in the endoplasmic reticulum (ER) and transported by CERT to Golgi, where 
SM is synthesized (Hanada et al., 2003). Glucosylceramides (GlcCer) are produced by 
glucosylceramide synthase (GCS) in a CERT-independent manner (a). In mitochondria, 
reactive oxygen species (ROS) activate neutral sphingomyelinase (NSMase) and in turn 
ceramide production. Mitochondrial ceramide can activate protein phosphatases PP1 
and PP2A. These are involved in inactivation of anti-apoptotic factors such as BCL2 
(Ruvolo et al., 1999) and Akt or activation of pro-apoptotic factors such an BID (b). De 
novo generated ceramide in the ER and nucleus activates PP1, which 
dephospohorylates SR proteins (Chalfant et al., 2001). SR proteins in turn regulate the 
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production of pro/apoptotic factors by alternatively splicing (c). In lysosomes, ASMase 
generates ceramide from SM and thereby can activate cathepsin D. Cathepsin-D 
activation triggers a signaling cascade leading to apoptosis (Heinrich et al., 2004). 
Lysosomal ceramide can be converted to sphingosine by acid ceramidase. Sphingosine 
is used as a substrate to generate other sphingolipids in different cellular 
compartments (d). Ceramide can be generated by secreted ASMase on the outer 
leaflet of the PM, where it might coalesce in lipid rafts (e). Ceramide enriched 
domains might affect signaling pathways (Henry et al., 2013). CDase, ceramidase; 
SMS, sphingomyelin synthase. (Ogretmen and Hannun, 2004) 
Within the complex network of ceramide metabolism there is one catabolite that stands out for its 
biologically well known signaling function, sphingosine-1-phosphate and its subsequent breakdown by S1P 
lyase. S1P binds to a family of five G-protein-coupled receptors and is implicated in angiogenesis, vascular 
maturation, cardiac development and immunity, as well as cell migration (Rosen et al., 2014). Recently, a 
role for S1P in endocytosis has been suggested (see discussion; Shen et al., 2014).  
 
The study of ceramides: technical issues  
The biological role of ceramides in membranes has been particularly difficult to study, due to technical 
limitations. Natural ceramides are highly hydrophobic and insoluble in water, therefore it is particularly 
difficult to tune their content in cells by add-back experiments (Kitatani and Luberto, 2010). This issue was 
often circumvented by employing synthetic short-chain ceramides such as C2 or C6. C2 and C6 are water-
soluble and represent valuable tools for add-back experiments. Studies with C2 and C6 strongly contributed 
to the advances in the field of sphingolipid research. However, short ceramide species do not occur in cell 
membranes and have different biophysical properties compared to natural ceramides. Therefore a careful 
interpretation of the results is needed. Other studies employed synthetic ceramides coupled to 
fluorophores, to enable their visualization in cells. Yet, the conjugation with these fluorophores alters the 
natural behavior of ceramides in membranes (Wang and Silvius, 2000). Again, this renders it difficult to 
interpret data from such add-back experiments.  
 
Fig. 13: C6-ceramide (above) and NBD-C6-ceramide (below). 
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The determination of the sub-cellular localization of ceramides remains a major challenge in the field. For 
some sphingolipids, an indirect visualization is possible by fluorescently tagging their ligand. Examples are 
cholera toxin for the detection of GM1 and lysenin to detect sphingomyelin (Sezgin et al., 2012; Yachi et al., 
2012). Theoretically, lysenin allows to visualize the conversion of SM to ceramide by live imaging, in the 
form of the disappearance of the lysenin signal. For this, experimental conditions must be tightly controlled 
and accurately designed. Antibodies against ceramide would represent a great tool to follow sub-cellular 
localization of ceramides. Although it is easy to recognize planar ceramides spotted onto membranes, e.g. 
in lipid overlay assays, it is more challenging to selectively recognize ceramides inserted into bio-
membranes, as they only expose a hydroxyl-group on the aqueous face of the membrane (Cowart et al., 
2002). Another challenge is to fix lipids and permeabilize cells without compromising the actual lipid 
architecture of membranes. 'Clickable ceramides' might be valid tools to study ceramide localization. 
Ceramide analogues coupled to an azide group either in the head or the tail can react in situ via 'click 
chemistry' and be fluorescently tagged (Garrido et al., 2012). Furthermore, lipid probes with 
photoactivatable and clickable groups offer an opportunity to address protein-lipid interactions in the 
cellular context (Peng et al., 2014). Whether experimental conditions preserve the natural lipid-protein 
landscape remains to be determined, however. 
Regarding ceramide quantification, the most commonly used biochemical methods are enzymatic 
diacylglycerol (DAG) kinase assay (Preiss et al., 1987), thin-layer chromatography (TLC; Górska et al., 2002) 
and high performance liquid chromatography (HPLC; Dobrzyń and Górski, 2002; Yano et al., 1998). 
Currently, the most valuable method for high-resolution ceramide profiling involves mass spectrometry 
(Bielawski et al., 2006; Merrill et al., 2005; Shaner et al., 2009; Sullards et al., 2007). 
 
 
2.2 Acid sphingomyelinase 
Sphingomyelinases (SMases) are important players in the sphingolipid metabolism. SMase are specialized 
phospholipases that catalyse the hydrolysis of sphingomyelin (SM) into ceramide (cer) and 
phosphorilcholine.  
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Fig. 14: Schematic representation of sphingomyelin hydrolysis to ceramide and 
phosphorylcholine by ASMase. (Jenkins et al., 2009) 
SMases are categorized into three groups: acid-, neutral- or alkaline-SMase depending on the pH for 
optimal activity. Of particular interest for this research project is acid sphingomyelinase. 
 
Human acid sphingomyelinase (ASMase) is ubiquitously expressed and enriched in the endothelium of 
blood vessels, Kupffer cells, spleen, bone marrow, lungs, and macrophages (Otterbach and Stoffel, 1995). 
ASMase is located in the lumen of acidic intracellular organelles, in particular lysosomes. ASMase shows an 
optimal enzymatic activity at pH of 4.5-5 (Callahan et al., 1983), but can hydrolyse sphingomyelin also at 
neutral pH, albeit with lower efficiency (Schissel et al., 1998). Lysosomal ASMase is protected from 
degradation in the acidic environment of lysosomes by glycosylation. Besides the lysosomal isoform, a 
second isoform of mature, functional ASMase is found in the secretory network and can be released from 
the cells (Schissel et al., 1996). The secreted isoform shows a different N-terminal processing and 
glycosylation profile and uses Zn2+ as a cofactor to hydrolyze SM at neutral pH (Callahan et al., 1983). Both 
isoforms derive from a common primary translation precursor, a pre-proform of 75 kDa. The pre-proform is 
subjected to removal of the signal peptide and converted into a 72 kDa proform in the ER/Golgi where it 
undergoes additional cleavages. This results in different forms of the peptide, such as Gly66 isolated from 
lysosomes, the secretory form His60 and a lysosomal Gly83 isolated from human placenta (Lansmann et al., 
1996; Schissel et al., 1996). All forms have Zn2+ binding motifs and can be activated by Zn2+, but only the 
lysosomal form encounters this ion during maturation and trafficking. For in vitro studies the activity of 
lysosomal ASMase is therefore independent of Zn2+, while secretory ASMase requires Zn2+ supplementation 
(Schissel et al., 1996). 
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ASMase constitutively catalyses the turnover of endocytosed sphingomyelin to ceramide in lysosomes and 
has a fundamental role in membrane homeostasis. Genetic mutations in ASMase lead to a lysosomal 
storage disorder named Niemann-Pick disease type A and B (NPD), with an incidence of 1 in 250’000  
(http://ghr.nlm.nih.gov/condition/niemann-pick-disease). NPD type A is caused by a severe deficiency in 
ASMase activity. The symptoms include neurodegeneration, which is manifested early after birth and leads 
to death within a few years. NPD type B retains some ASMase activity, sufficient to support the 
development of the neural system, but leads to later onset of pathology, underlined by abnormal 
accumulation of lipids in spleen, liver, lungs, bone marrow or brain (McGovern et al., 2013). Accumulation 
of sphingomyelin is often accompanied by disorders in cholesterol metabolism and causes the dysfunction 
of lysosomes (McGovern et al., 2004). Symptoms and severity of NPD type B depend on the residual 
ASMase activity. Generally NPD type B patients survive into adulthood without neurodegeneration 
(Schuchman, 2001). 
 
Besides a constitutive function, ASMase can be activated in response to cellular stress. This increases the 
ceramide levels at the plasma membrane. This aspect has been extensively studied and a wide variety of 
stimuli have been identified, including cytokines, differentiation agents, anti-cancer drugs and ligation of 
death receptor-ligands and TNF receptor family members. In addition, physical stress, such as UV-light and 
ionizing radiation or chemical stress from ROS were reported to activate ASMase. The resulting cellular 
response is in most cases either apoptosis, arrest of cell growth or the stimulation of innate immunity 
(Henry et al., 2013; Stancevic and Kolesnick, 2010). A common feature of ASMase activation is the 
generation of ceramide enriched domains, which reorganizes PM sub-domains and thereby modulates 
signal transduction (Stancevic and Kolesnick, 2010). Notably, underlining mechanisms of ASMase 
translocation to the PM following stress signaling remain elusive. 
 
2.3 Plasma membrane repair and acid sphingomyelinase 
Biological, chemical and mechanical stress can trigger membrane perforation. Cell survival to wounding 
entirely depends on the efficiency of limiting the efflux of cytosolic components. Independent of the nature 
of the lesion, strategies to sense wounding and to repair the plasma membrane have to be readily available 
for cell survival. Indeed PM resealing occurs rapidly, within a few seconds. This involves processes 
dependent on extracellular calcium (Andrews et al., 2014). Extracellular calcium concentrations are 
approximately 1 mM, while cytosolic calcium concentrations are actively kept very low, around 100 nm 
(Syntichaki and Tavernarakis, 2003). Calcium normally does not freely diffuse through intact membranes 
but is transported through selective channels. However, when the PM is injured, calcium flows through the 
lesion and leads to a sudden increase its cytosolic concentration (Draeger et al., 2011). The small size of this 
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ion and the considerable difference between extracellular and intracellular levels ensures an increase in 
cytosolic calcium even after minor wounding events. Calcium is a key factor in signaling wounding and 
triggering the cellular responses for repair (Draeger et al., 2014). 
 
Lysosomal excocytosis, acid sphingomyelinase and endocytosis of the lesions 
Intracellular calcium increase triggers the exocytosis of lysosomes, mostly the membrane-proximal subset 
of lysosomes (Jaiswal et al., 2002; Rodríguez et al., 1997). Lysosomal exocytosis was first observed in cells 
containing specialized secretory organelles, such as melanocytes, cytotoxic lymphocytes and alveolar cells 
(Griffiths, 1996). It later emerged that Ca2+-triggered exocytosis extends to a multitude of cells types, 
including for example muscle fibers (Andrews, 2000; Bergsbaken et al., 2011; Griffiths, 1996; Keefe et al., 
2005). Exocytosis is modulated by the lysosomal proteins synaptotagmin VII (syt VII) and mucolipin-1. While 
syt VII senses calcium and promotes fusion of lysosomes with the PM (Pang and Südhof, 2010), mucolipin-1 
is a non-selective cation channel through which cytosolic calcium concentration can be modulated (Medina 
et al., 2011).  
 
The mechanisms of how lysosomal exocytosis contributes to membrane repair are currently debated 
(Andrews et al., 2014; Draeger et al., 2014). Exocytosis provides additional membranes that either facilitate 
spontaneous resealing by decreasing the overall membrane surface tension (Togo et al., 2000). 
Alternatively, they might directly ‚patch‘ the lesions (McNeil et al., 2000). Studies with pore-forming 
proteins such as bacterial streptolysin-O (SLO) and perforins released by cytotoxic lymphocytes revealed 
that injured cells undergo extensive endocytosis. Pores localize into numerous endocytic vesicles seconds 
after wounding and are found in larger vesicles after few minutes (Idone et al., 2008; Keefe et al., 2005). 
Remarkably, PM resealing by endocytosis is a common mechanism also found in non-mammals, such as 
crayfish neurons (Eddleman et al., 1998), or intestinal cells of C. elegans (Los et al., 2011). 
 
Lysosomal exocytosis implies the release of lumenal hydrolases to the outer leaflet of the PM. Among these 
enzymes, ASMase emerged as a key regulator of endocytosis. Cells with reduced ASMase activity by either 
drug treatment, siRNA mediated knock down, or genetic mutation are competent for lysosomal exocytosis, 
but fail to produce surface ceramide (Babiychuk et al., 2008) and endocytosis mediated PM sealing (Tam et 
al., 2010). Importantly, the add-back of exogenous bSMase fully restores PM repair (Tam et al., 2010) even 
in absence of extracellular calcium (Tam et al., 2013a). This suggests that ASMase is the primary mediator 
of endocytosis and membrane sealing. Which cellular machinery is involved in ASMase-mediated 
endocytosis is still under characterization. ASMase-mediated PM repair involved dynamin-independent 
endocytosis (Corrotte et al., 2013; Idone et al., 2008; Tam et al., 2010).   
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Besides ceramide, cholesterol is required for endocytosis after PM injury (Idone et al., 2008; Lariccia et al., 
2011). Cholesterol is known to associate with lipid rafts with SM and these rafts participate to caveolin-
mediated endocytosis (Simons and Sampaio, 2011). Remarkably, siRNA mediated knock-down of caveolin 
inhibited the repair of cells wounded with SLO, and SLO pores were found to internalize in caveolin positive 
compartments (Corrotte et al., 2013). Other stress conditions, such as osmotic shock (Parton et al., 1994) 
and detachment from the substrate (del Pozo et al., 2005) triggered caveolar mediated endocytosis. In line 
with these findings, several cell types exposed to mechanical stress such as endothelial cells, adipocytes 
and muscle fibers show an enrichment in caveolar structures proximal to the PM (Parton and Simons, 
2007). Accordingly, a role for caveolar endocytosis is proposed in maintaining sarcolemmal integrity of the 
sarcolemma in muscle cells (Bonilla et al., 1981; Gazzerro et al., 2010; Rajab et al., 2010; Repetto et al., 
1999; Zhu et al., 2011). However, if lipid rafts/caveolin is the only endocytic pathway capable of 
endocytosis for PM repair remains an open question (Andrews et al., 2014).  
 
PM blebbing, isolation of lesion in membranes and microvesicle shedding 
PM permeabilization with SLO or employing UV laser revealed a cellular response involving the formation 
of PM blebs towards the extracellular space (Idone et al., 2008; Jimenez et al., 2014). Such blebs have been 
associated to transient remodeling of the actin cytoskeleton triggered by cytosolic calcium (Charras et al., 
2006). These blebs might be either retracted or shed. Both possibilities are plausible and the outcome 
might depend on the amplitude of the calcium transients and the efficiency of membrane resealing (Idone 
et al., 2008). The shedding of microvesicles has been shown to remove pores induced by the complement 
(Morgan, 1989) as well as pores formed by bacterial toxins (Babiychuk et al., 2009; Keyel et al., 2011; Potez 
et al., 2011). The release of microvesicles is regulated by proteins of the annexin family (Atanassoff et al., 
2014; Babiychuk et al., 2009; Potez et al., 2011). Annexins are ubiquitously expressed calcium sensitive 
proteins, that re-localize from the cytosol to the plasma membrane following intracellular calcium increase 
(Monastyrskaya et al., 2007). Annexins are capable of binding to negatively-charged phospholipids and 
fusing membranes (Babiychuk et al., 2009; Creutz et al., 1978; Potez et al., 2011). By these properties, 
annexins are proposed to be rapidly recruited to the site of wounding  and fuse the tips of the membrane 
bleb enclosing the lesion (Atanassoff et al., 2014; Babiychuk et al., 2009; Bouter et al., 2011; McNeil et al., 
2006; Potez et al., 2011). 
 
Membrane blebbing also involves components of the ESCRT machinery (Jimenez et al., 2014). CHMP4B, 
CHMP2aA and Vps4 are recruited to the wounded sites and contribute to the repair of small openings (size 
< 100 nm), but not large lesions (Jimenez et al., 2014). The vesicles generated by ESCRT are generally about 
50 nm in diameter (Cashikar et al., 2014; Murk et al., 2003) but membrane protrusions following PM injury 
range between 200 to 500 nm in size (Jimenez et al., 2014). Besides the discrepancy in the dimensions, 
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there is an additional issue with the timing: the recruitment of the ESCRT machinery to the wounded sites 
occurs in an energy independent manner, but too slowly to mediate resealing within a few seconds 
(Corrotte et al., 2013; Jimenez et al., 2014; McNeil and Kirchhausen, 2005; McNeil et al., 2000). Further 
investigations are required to understand the precise involvement of the ESCRT components in PM repair. 
 
Using shedding or endocytosis, cells have evolved mechanisms to promptly isolate and remove lesions from 
the plasma membrane. Which repair strategy will be chosen depends on the cell type and morphology, the 
size and localization of the lesion and the extent of calcium influx. All in all, these processes collaborate to 
avoid catastrophic events of cell 'explosion' and ensure either full recovery of the compromised cells, or 
controlled cell death by apoptosis (Andrews et al., 2014; Draeger et al., 2014).  
 
3. ADENOVIRIDAE 
Adenoviruses are non-enveloped, double-stranded DNA viruses of about 90 nm (van Oostrum and Burnett, 
1985). The family of Adenoviridae comprises 5 genera, infecting a broad variety of vertebrates. Human 
adenoviruses (HAdV) are the largest genus, and encompasses more than 60 characterized species. HAdV 
are associated to diseases of the upper and lower respiratory tract, gastroenteritis and conjunctivitis 
depending on the serotype (Table 1; Zhang and Bergelson, 2005). Infection symptoms are generally mild in 
adult immunocompetent individuals, but can be severe and life-threatening in children and 
immunocompromised people. 
 
Species Serotype Tropism/ Diseases 
A 12, 18, 31 Intestinal / Cryptic enteric infections 
B1 3, 7, 16, 21, 50 Respiratory / Upper-airway infections 
B2 11, 14, 34, 35 Renal/ Kidney and urinary tract 
infections 
C 1, 2, 5, 6 Respiratory / Upper-airway infections, 
liver infections 
D 8, 9, 10, 13, 15, 17, 19, 20, 22-30, 32, 33, 36-39, 42-
47, 48, 49, 51 
Ocular and other infections/ Epidemic 
keratoconjunctivitis 
E 4 Respiratory/ Pneumonia 
F 40, 41 Intestinal/ Gastroenteritis 
G 52 Intestinal / Gastroenteritis 
 
 
Table 1: Classification and diseases of human adenoviruses. (modified from Zhang and Bergelson, 2005) 
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Since their discovery by Rowe et al. in the fifties (Rowe et al., 1953) HAdV served as a tool to enlighten cell 
biology processes and host-pathogen interactions. HAdV are currently widely employed as oncolytic and 
gene therapy vectors (Wold and Toth, 2013). 
HAdV has an icosahedral shell composed of three major proteins associated into 240 trimeric hexons, 12 
pentameric penton base proteins at each vertex and 12 trimeric fiber proteins. Fibers are anchored to the 
penton base, protrude from the capsid and mediate attachment to host receptors via the globular knob 
domain. The capsid is additionally stabilized by complex networks involving the four minor proteins IIIa, VI, 
VIII and IX (Burnett, 1985; Stewart et al., 1993). Despite the recently accomplished great advances in 
solving adenoviral structures by crystallography and cryo-EM (Liu et al., 2010; Reddy et al., 2010; Reddy and 
Nemerow, 2014), the exhaustive 3D map of the minor proteins remains a matter of debate.   
     
Fig. 15: Representation of an adenovirus with structural components highlighted. GON: 'groups of 
nine' are the hexon trimers that form a planar sheet-like structure within each face. GOS: 
'group of six', assembly of 'peripentonal hexons' and pentons. (Harrison, 2010) 
 
The importance of the minor proteins for virus infectivity emerged by studying the HAdV-C2 temperature 
sensitive mutant Ts1. Ts1 is successfully internalized by host cells but fails capsid maturation, uncoating and 
endosomal escape (Hannan et al., 1983). This phenotype is attributed to a point mutation in the viral 
cysteine protease L3/p23 (Imelli et al., 2009). The viral cysteine protease L3/p23 is located in the interior of 
the immature virion, is fully activated by binding to DNA and VI (Graziano et al., 2013; Mangel et al., 1993; 
Webster et al., 1993) and processes IIIa, VI, and VIII as well as the core components VII, X and the terminal 
protein (TP) (Hassell and Weber, 1978; Rancourt et al., 1995; Russell, 2009).  
Protein VI is a 23 kDa polypeptide, present in about 360 copies per virion (Benevento et al., 2014; 
Lehmberg et al., 1999; van Oostrum and Burnett, 1985), with multiple functions during the whole viral life 
cycle. During entry and replication mature VI is indispensable for endosomal escape (Wiethoff et al., 2005) 
and prevents suppression of viral gene expression by innate immune components such as Daxx (Schreiner 
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et al., 2012). During viral assembly and maturation, immature VI shuttles the hexon trimers into the nucleus 
and triggers viral maturation (McGrath et al., 2003). In the intact virus, VI is likely located underneath the 
hexon trimers (Liu et al., 2010), with one VI tightly associated to each peripentonal hexon (Reddy and 
Nemerow, 2014) and interacts with the core protein V (Matthews and Russell, 1998). Yet, it remains 
difficult to understand the full picture of VI positioning: 360 copies of VI are too much for being associated 
one per hexon trimer (copy number 240) but too low to bind one per hexon (copy number 720) (San 
Martín, 2012).  
 
During endocytosis and capsid uncoating, VI is exposed to the viral surface and its N-term domain folds into 
an amphipathic alpha-helix (Burckhardt et al., 2011; Reddy and Nemerow, 2014; Wiethoff et al., 2005). The 
role of VI in endosomal escape is further discussed in the section Adenovirus entry and penetration. 
Protein IX is present in 240 copies per capsid (van Oostrum and Burnett, 1985), and is the only minor 
protein exposed to the surface of the intact virion (San Martín, 2012). IX is not essential for virus assembly 
but strongly contributes to the virion stability (Colby end Shenk, 1981). According to Liu et al., trimers of 
protein IX form a stable network on the capsid shell, where both C- and N-termini are exposed on the 
surface of the virion (Liu et al., 2010). Trimers of IX are interconnected by four helix bundles involving three 
C-term and one N-term and a trimeric joint of N-term domains with an hydrophobic core.  
Protein IIIa is proposed to assemble under each vertex in a ring of 5 monomers, for a total copy number of 
60. Several residues of IIIa (300 to 585) could not be traced by cryo-EM (Liu et al., 2010), suggesting that 
these residues interact with the core of the capsid which is non-icosahedral (San Martín, 2012). IIIa is 
proposed on the one hand to stabilize assembling and intact capsids and on the other hand to promote the 
release of vertices and genome during uncoating (D'Halluin et al., 1978; San Martín, 2012; San Martín et al., 
2008). 
The 120 copies of protein VIII are in the inner capsid, underneath the boundaries of penton bases and 
hexons (Liu et al., 2010). 
 
3.1 Adenovirus entry and penetration 
The overall process of adenovirus entry involves attachment to the host, internalization, endosomal escape, 
uncoating and delivery of the viral genome to the nucleus. Best studied is the entry pathway of the closely 
related serotypes HAdV-C2 and HAdV-C5. The specificity of HAdV-C2/5 for the host is mediated by the high 
affinity binding (Kd=15 nM) of the distal knob domain of the viral fiber to the coxsackievirus B and 
adenovirus receptor (CAR) (Bergelson et al., 1997; Howitt et al., 2003; Kirby et al., 2000). CAR is a type 1 
transmembrane protein of the immunoglobulin superfamily, expressed in several human tissues including 
lung, liver, heart and brain and involved in cell‐cell contacts and adherent‐junctions (Howitt et al., 2003). 
Viruses bound to CAR undergo drifts on the plasma membrane, and confined motions that depend on 
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actomyosin-2, until they engage with immobile ανβ3 or ανβ5 integrins via the RGD domain on penton base 
(Burckhardt et al., 2011; Chiu et al., 1999; Wickham et al., 1993). Viruses anchored to integrins and 
simultaneously drifting on CAR are subjected to mechanical forces that trigger the release of the fibers, 
thereby initiating the stepwise uncoating program of the viral capsid (Burckhardt et al., 2011; Greber et al., 
1993; Nakano et al., 2000). The integrin/penton base interaction induces the clockwise untwisting of the 
pentamere and further loosens the viral capsid (Lindert et al., 2009). Fiber loss is essential for infection 
(Nakano et al., 2000) and surface signaling events involving integrin stimulated clathrin- and dynamin 
mediated endocytosis of the viruses (Shayakhmetov et al., 2005). Internalization might be facilitated by the 
recruitment of the adaptor complex AP-2 by the NPXY (asparagine-proline-any amino acid-tyrosine) motif 
in β3 or β5 (Gastaldelli et al., 2008; Meier et al., 2002; Wang et al., 2000; Wolfrum and Greber, 2013). 
 
In coordination with endocytosis, capsids undergo a stepwise dismantling program and start to release the 
major coat proteins penton and hexon, as well as the stabilizing proteins IX and VI (Greber et al., 1993; 
Martin-Fernandez et al., 2004). A crucial event for endosomal escape is the externalization of the inner 
capsid protein VI. VI has an N-terminal amphipathic α-helix (residues 34 to 54) with proposed membrane 
lytic activity (Wiethoff et al., 2005). This function was first suggested by in vitro experiments, in particular it 
was observed that heat-uncoated viruses lose the ability to lyse liposomes if VI is immunodepleted 
(Wiethoff et al., 2005). Of note, infectivity of HAdV-C5 and co-delivery to the cytosol of the toxin saporin 
were reduced in cells pre-incubated with anti-VI antibodies used for immunodepletion (Maier et al., 2010). 
Additional studies with recombinant versions of VI identified the residues 34 to 54 as being responsible for 
membrane disruption in a pH independent manner (Maier et al., 2010; Wiethoff et al., 2005). Importantly, 
the mutant VI-L40Q shows reduced membrane lytic capacities in vitro and HAdV-C5-VI-L40Q is less 
infectious compared to HAdV-C5 (Moyer et al., 2011). Another mutation in the alpha-helical domain of VI, 
G48C, also lowered in vitro membrane disruption capacities (Moyer and Nemerow, 2012). In addition, the 
insertion of cystein led to the formation of aberrant disulfide bonds between VI within the capsid.  
 
As a consequence, VI release on the plasma membrane or endosomes was impaired (Moyer and Nemerow, 
2012). Attempts to elucidate the mechanisms of lysis indicated that recombinant VI binds to model 
membranes in a parallel orientation and induces positive membrane curvature, thereby likely triggering 
membrane fragmentation (Maier et al., 2010). In contrast, VI-L40Q displays a different pattern of 
membrane interaction. Still, the precise mechanism of how the amphipathic alpha helical domain of VI 
lyses membranes remains poorly understood (Moyer and Nemerow, 2011). Part of the 360 copies of VI is 
proposed to be released from the capsid and associate to endosomal membranes (Maier et al., 2012). The 
rest of VI gets degraded presumably by virtue of the viral L3/p23 protease (Greber 1993, 1996).  
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By engaging with dynein intermediate chain and exploiting dynactin dependent transport (Kelkar et al., 
2004; Suomalainen et al., 1999) capsids reach the nucleus. There, they dock on Nup214/Nup88 at the 
nuclear pore complex (NPC) (Trotman et al., 2001). The docking is mediated by the nucleoporin Nup214, 
and uncoating is facilitated by Nup358 which activates the heavy chain Kif5c of kinesin-1 (Strunze et al., 
2011). Kinesin motions provide the pulling force to complete capsid uncoating, and partially compromise 
the integrity of the NPC. The viral genome is finally imported into the nucleus with the contribution of 
additional factors, including the histone H1,  importin β1, β2 and β7 (Hindley et al., 2007; Saphire et al., 
2000; Trotman et al., 2001; Wodrich et al., 2006). 
 
During the early phase of infection regulatory proteins are synthesized to promote cell replication (Frisch 
and Mymryk, 2002), to suppress the detection of viral components by the immune system (Lichtenstein et 
al., 2004) and to block the cellular DNA damage response machinery (Bischoff et al., 1996). Meanwhile, the 
replication of the viral DNA is initiated. In the late phase structural components of the virus are produced 
and the new virions are assembled. The viral life cycle culminates with the release of the mature progeny 
viruses by cell lysis (Tollefson et al., 1996).  
AIM OF THE THESIS 
 
How HAdVs interact with lipids to cross host membranes remains poorly understood. The aim of this thesis 
is to identify and study specific lipid requirements during entry of HAdV-C2/C5. A particular focus is given to 
the differences between WT and the escape mutant Ts1, with the intention to reveal lipid rearrangements 
that specifically support viral escape from endosomes. Moreover, the molecular mechanisms underlining 
the regulation of lipids by incoming HAdV will be addressed. 
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Using mass spectrometry, we followed 159 lipid species during early steps of adenovirus infection. Only 
two ceramide species were significantly up-regulated at 30 minutes after infection with HAdV-C2 (Log2 fold 
change > 0.4, P-value < 0.05). Ceramide remodeling was induced by WT adenovirus but not by TS1 (Fig. 1a), 
a mutant that successfully engages with the primary receptor CAR and the co-receptor integrins but fails to 
uncoat and cross the endosomal membrane (Burckhardt et al., 2011; Gastaldelli et al., 2008; Greber et al., 
1996; Nakano et al., 2000; Pérez-Berná et al., 2009). Ceramides are essential structural components of 
membranes and potent signalling factors involved in membrane microdomain function, such as formation 
of vesicles, cell signalling, or cell death (Bartke and Hannun, 2009; Goñi and Alonso, 2009).  To identify 
which ceramide biosynthesis pathway was activated by incoming HAdV, we used a set of inhibitors 
targeting ceramide de novo synthesis (He et al., 2004), salvage pathway (Wang et al., 1991), and neutral 
(Luberto et al., 2002) and acid sphingomyelin hydrolysis (Kornhuber et al., 2008) (Fig. 1b).  Solely inhibition 
or silencing of acid sphingomyelinase (ASMase) reduced adenovirus infection (Fig. 1 c,d, and S1a, d-f). On-
target action of amitriptyline and siRNA against ASMase was confirmed by measuring the enzymatic 
hydrolysis of 6-Hexadecanoylamino-4-methylumbelliferylphosphorylcholine (HMU-PC), a fluorogenic, 
specific ASMase substrate (van Diggelen et al., 2005) (Fig. 1e). To further validate the requirement of 
ASMase for infection, we performed gain-of-function experiments in untransformed fibroblasts (GM00112) 
that exhibit no detectable ASMase activity (Levran et al., 1992). When the inoculum was supplemented 
with purified bacterial sphingomyelinase (bSMase), the infection level was strikingly  increased (Fig. 1f). 
ASMase is a fundamental regulator of membrane homeostasis and constitutively hydrolyses sphingomyelin 
(SM)  into Cer and phosphorilcholine in late endosomes and lysosomes (Ferlinz et al., 1994). SM plays an 
essential role in formation of lipid rafts (McIntosh et al., 1992), is enriched in the outer leaflet of the plasma 
membrane and traffics through the endolysosomal network (Koivusalo et al., 2007). To unravel the function 
of ceramide early in infection, we inhibited lysosomal ASMase by amitriptyline and dissected specific virus 
entry steps. Virus attachment and the initial step of uncoating, CAR mediated fiber shedding, were 
unaffected (Fig. S2a,b). However, we found that ASMase inhibition delayed the kinetics of adenovirus 
endocytosis (Fig. S2 c,d). BSMase addition to the inoculum rapidly increased ceramides (Fig. 2i), readily 
rescued the uptake of HAdV-C2 and accelerated internalization of TS1 (Fig. S2 d,e). Competitive inhibition 
of bSMase by HMU-PC, which is a soluble bSMase substrate, blocked the rescue (Fig. S2d,e). This underlines 
the specific requirement of the sphingomyelinase activity for HAdV infection. The results revealed that a 
spatiotemporal increase in ceramide abundance enhances virus internalization. Rapid internalization is 
critical for productive infection, as in the natural site of infection viral particles exposed extracellularly are 
vulnerable to neutralization by immune system mediators (Hendrickx et al., 2014; Smith and Nemerow, 
2008). 
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Endocytosed virions traffic to early endosomal compartments, where the stepwise uncoating process 
culminates in the externalization of the membrane lytic factor protein VI (Burckhardt et al., 2011; Wiethoff 
et al., 2005). Protein VI interacts with lipid bilayers in vitro (Wiethoff et al., 2005) and mediates endosomal 
escape of the virus  in vivo (Maier et al., 2010; Moyer and Nemerow, 2012; Moyer et al., 2011). Yet, how 
the lipid landscape influences this process is not known. To examine the involvement of ceramide in 
endosomal penetration, we analyzed the exposure and retention of VI on internalized viruses. While 
inhibition of ASMase reduced the exposure of VI, simultaneous addition of exogenous bSMase fully 
reverted this effect (Fig. 2a). We next determined the penetration efficiency by measuring cytosolic viruses 
using the SLO immunofluorescence assay and also EM analyses (Suomalainen et al., 2013). To exclude 
effects reminiscent of the kinetic delay in endocytosis, we evaluated endosomal escape when most viral 
particles were already internalized (Fig. S2f,g). Notably, limited VI exposure directly correlated with reduced 
endosomal escape (Fig. 2b, S2f). Interestingly, the addition of bSMase rescued the escape efficiency of WT 
virus, while TS1, which fails to expose VI, remained trapped in the endolysosomal network (Fig.  2b). These 
findings indicate that ceramide production at the plasma membrane before or during viral endocytosis 
enhances viral uptake and escape from endosomes. We next assessed if VI specifically interacted with 
ceramide-rich membranes. Partially uncoated viral particles (Fig. 2d) were exposed to liposomes composed 
of  either POPC, POPC:SM 99:1 or POPC:CER 99:1. Liposomes bound to viral proteins were separated from 
empty liposomes and unbound viral components by floatation. The isolated fractions were and analyzed by 
immunogold EM with an antibody against VI (Fig. 2c,e). While VI floating with POPC vesicles was nearly 
undetectable, VI strikingly associated with sphingolipids containing membranes, with a strong preference 
for ceramide over SM (Fig. 2e,f). To analyze how these interactions influence the integrity of liposomes, we 
performed liposomes leakage assays (Fig. 2g). Liposomes were produced using total lipid extracts from 
HeLa cells (Wu et al., 1980), and enriched in ceramide by bSMase treatment (Fig. 2g). Uncoated HAdV-C5 
triggered lysis of liposomes, a phenomenon that was remarkably enhanced by ceramide (Fig. 2h). To 
address the role of VI in this process, we tested the HAdV-C5 mutant VI-L40Q. L40Q harbors a point 
mutation in the N-terminal amphipathic α-helix of VI and exhibits attenuated membrane lysis activity 
(Moyer et al., 2011). VI-L40Q led to limited leakage of high-ceramide liposomes at equal doses as WT virus. 
This confirmed that VI is the primary mediator of leakage (Fig. 2h). Together, the results support a model 
where a lipid microenvironment enriched in ceramide favors endocytosis and endosomal escape. 
How do incoming viruses ensure lipid remodeling at the right time and at the right place? We wondered if 
the lysosomal ASMase is subjected to re-localization during infection. To test this, we collected the 
supernatant of infected cells and measured the enzymatic activity of ASMase and another lysosomal 
enzyme, β-hexosaminidase (Rodríguez et al., 1997; van Diggelen et al., 2005). We found that the activity of 
both enzymes was increased at the exoplasmic leaflet of the PM immediately following virus binding (Fig. 
3a,b, S3a,b). This event was ligand-specific, as TS1, cholera toxin B or competitive inhibition of virus binding 
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by soluble CAR (CARexFC) (Ebbinghaus et al., 2001) did not lead to release of ASMase or β-hexosaminidase 
into the supernatant (Fig. 3a). Importantly, β-hexosaminidase translocation was independent of ASMase 
activity, as HAdV inoculated cells treated with amitriptyline also released β-hexosaminidase (Fig. 3a). 
Neither control nor  infected cells released the cytosolic enzyme lactate dehydrogenase, a tetramer with a 
molecular weight of about 140 kDa (Evans et al., 1985), indicating that the plasma membrane was not 
severely damaged by the virus (Fig. S3a,b). Lysosomal exocytosis is involved in the repair of small wounds in 
the plasma membrane (Idone et al., 2008; Tam et al., 2010) and is triggered by the influx of extracellular 
Ca2+ through the lesions. In accordance, lysosomal exocytosis was completely abrogated without 
extracellular Ca2+ but occurred normally without extracellular magnesium (Fig. 3c).  
To visualize the dynamics of Ca2+ fluxes, cells expressing the Ca2+ sensor GCamP5G (Akerboom et al., 2012) 
were imaged during infection. While resting cells rarely showed spontaneous Ca2+ spikes, infected cells 
showed frequent, multiple and rapid increases in cytosolic Ca2+ coinciding with virus binding and 
endocytosis (Fig. 3e). This phenomenon was not observed with TS1 infection or in absence of extracellular 
Ca2+ (Fig. S4a,b).  Of note, abrogation of extracellular Ca2+ after virus binding delayed endocytosis of WT but 
not Ts1 and reduced infection, consistent with being a trigger for lysosomal exocytosis (Fig. S3d-f). 
Lysosomal exocytosis was linked to viral escape, as both events were inhibited by nocodazole treatment 
(Fig. 3c,d, and S3g).  Notably, the absence of lysosomal exocytosis could be bypassed by the addition of 
bSMase in the inoculum, indicating that surface ASMase was a critical factor to enhance virus escape from 
endosomes (Fig. 3d). 
To identify how extracellular Ca2+ accessed the cytosol, we analyzed integrity of the plasma membrane by 
time-lapse imaging of propidium iodide (PI), a membrane impermeant nucleic acid dye (Jimenez et al., 
2014). Incoming HAdV-C5 provoked the influx of PI from the extracellular medium, visible as discrete spots 
at the cell periphery (Fig. 3f). The influx of PI was quickly resolved and always correlated to cytosolic Ca2+ 
spikes (Fig. 3f,g), suggesting the existence of transient and rapidly resealing membrane lesions. In rare 
cases, cells exhibited a non-resolvable PI staining (Fig. 3g, S4d), likely indicating a failure of lesion repair. 
This was supported by the notion that these cells showed extensive plasma membrane blebbing, which can 
be a predictor for apoptosis (Fig. S4d) and (Jimenez et al., 2014).  
We next tested the hypothesis that the transient membrane lesions were caused by a release of viral 
factors from the incoming virus. We monitored PI fluxes in cells expressing Dyn2K44A-GFP, conditions that 
block viral endocytosis but not the release of the fibers (Meier et al., 2002; Nakano et al., 2000). The results 
show that influx of PI occurs in presence of Dyn2K44A-GFP, indicating that the plasma membrane is 
permeabilized by incoming virus (Fig. S4f). We next tested if VI was involved in membrane 
permeabilization. The permeabilization of cells exposed to either VI-L40Q or uncoated HAdV-C5 incubated 
with a neutralizing anti-VI antibody was significantly reduced (Fig. 3h,i, S3e). These observations are in 
accordance with previous reports showing a capacity of uncoating competent viruses to permeabilize 
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cellular membranes (Di Paolo et al., 2013; Wickham et al., 1994). Collectively, our data establish a model for 
how an incoming non-enveloped virus harnesses Ca2+ signaling to hijack host lipid metabolism, produces 
specific lipid signatures and effectively overcomes the host cell membrane (Fig. 4).  
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Figure 1: Ceramides generated by acid sphingomyelinase are selectively enriched by 
incoming adenovirus and support infection 
a) Comparative lipidomics of HeLa Ohio cells infected for 30 min with either HAdV-C2 
or TS1 is shown. Ceramide species are highlighted.  
b) Schematic representation of selected ceramide generating pathways and respective 
inhibitors. 
c,d,e) Chemical inhibition and silencing of ASMase reduced infection and ASMase 
cellular activity. HeLa Ohio cells were treated with the indicated drugs for 4h before 
and 16h during infection or transfected using lipofectamine (Lipo) with siRNA 
sequences specific for ASMase (siASM1, siASM2), GFP (siGFP), or non targeted 
sequences (siNT) for 72h before infection. Lysates of treated cells were incubated with 
HMU-PC, a fluorogenic substrate of ASMase.  
f) Addition of bSMase to the inoculum enhanced infection of GM00112 cells. Scale 
bar=200 µM. 
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Figure 2: ceramide interacts with the capsid protein VI to mediate efficient 
endosomal escape 
 
a) ASMase inhibition reduced VI exposure. Cells were pre-treated 4h with either 
DMEM-0.2% FAF BSA or 25 µM Ami, then exposed to cold-binding with HAdV-C5-
Atto565. The samples were incubated for 5 min at 37°C in medium supplemented 
either with Ami, 0.012 U/ml bSMase or bSMase mixed with a 150-fold excess of its in 
vitro substrate HMU-PC. Surface viruses were recognized by incubation at 4°C with the 
9C12 anti-hexon antibody in unfixed, unpermeabilized cells. Viruses positive for 
Atto565 but negative for 9C12 staining were scored as internalized, and VI exposure 
on internalized particles was evaluated.  Scale bar=5 µm. 
b) ASMase inhibition reduced escape to the cytosol. Infection was performed as 
described above. Cytosolic but not endosomal HAdV-C2-Alexa488 or TS1-Alexa488 
were accessible to immunofluorescence labeling in SLO-treated cells after virus 
internalization.  
c)  Schematic representation of a liposome binding assay. Top fractions were 
subjected to  immunogold  labeling of VI and analyzed by EM. 
d) In vitro virus uncoating, immunogold labeling of VI and EM analysis showed VI 
exposure on heat treated capsids. 
e,f) VI preferentially binds to liposomes containing ceramide, as shown by EM 
micrographs of liposomes bound to VI and quantification of % positive liposomes (a 
minimum of 250 liposomes were analyzed per condition). Scale bar=100 nm. 
g,h) Leakage is enhanced in ceramide-rich liposomes. Schematic representation of a 
liposome leakage assay. 6-carboxyfluorescein entrapped liposomes were exposed to 
bSMase or left untreated. Liposomes were further incubated with uncoated HAdV-C5-
EGFP or uncoated HAdV-C5-L40Q. 100% liposomes leakage was determined by 
incubation with Triton X-100. 
i) BSMase exogenously added to the supernatant rapidly increased ceramide levels in 
HeLa Ohio cells.  
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Figure 3:  Incoming adenovirus permeabilizes the plasma membrane to harness 
calcium signaling and trigger lysosomal exocytosis 
a-c) Incoming adenovirus induces calcium-dependent lysosomal exocytosis. The 
activity of either the lysosomal enzymes β-hexosaminidase or ASMase in the 
supernatant of cells exposed to the indicated ligands in the specified media was 
determined at 45 min warm infection in a, and at various time points or at 15 min of a 
cold-synchronized infection in b and c respectively. 
d)  Lysosomal exocytosis accelerated endosomal escape. Cells were pre-treated with 
nocodazole and exposed to bSMase during 20 min of infection. Cytosolic but not 
endosomal HAdV-C2-Alexa488 was stained by immunofluorescence labeling in SLO-
treated cells after virus internalization.  
e-g) Incoming adenovirus permeabilizes the PM. Cytosolic Ca2+ transients and 
propidium iodide influx were analyzed in cells expressing GCamP5G during the first 
minutes of infection, either by confocal microscopy or by flow cytometry. Scale bar=10 
µM. 
h,i) VI contributes to PM permeabilization. In presence of propidium iodide, cells were 
exposed either to intact HAdV-C5 and the mutant VI-L40Q or to heat-uncoated HAdV-
C2 pre-incubated with the indicated antibodies. 
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  Figure 4: 
 
 
Figure 4: Working model 
1. Uncoating competent adenovirus induces transient PM 
permeabilization mediated by VI. This leads to the influx of 
extracellular Ca2+ in the cytosol. 
2. Increase in cytosolic Ca2+ triggers lysosomal exocytosis and 
delivers ASMase to the outer leaflet of the PM. 
3,4. ASMase converts sphingomyelin (SM) to ceramide (CER). 
Ceramide increase supports virus endocytosis. 
5. Protein VI interacts with CER to enhance endosomal lysis. 
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Figure S1: The ASMase inhibitor amitriptyline (Ami) reduces infection and is not toxic to cells 
a) HeLa Ohio cells were pre-treated with 25 µM with Ami in DMEM-0.2% FAF BSA and infected with HAdV-
C2 for 18 h in presence of the drug. Newly synthesized hexon was stained in fixed cells and the percent of 
infection was evaluated. Scale bar=200 µM. 
b) HeLa Ohio cells were incubated with Ami in DMEM-0.2% FAF BSA for 24 h and metabolic activity was 
assessed by resazurin assay. 
c) Late addition of Ami does not reduce HAdV-C5_EGFP infection in HeLa Ohio cells. 
d) Ami inhibits infection of a B-specie adenovirus. HeLa Ohio cells were pre-treated with 25 µM with Ami in 
DMEM-0.2% FAF BSA and infected with HAdV-B3_EGFP  for 22 h in presence of the drug.  
e,f) Ami treatment reduces infection of HAdV-C5_EGFP in primary nasal cells and A549. 
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Figure S2: ASMase inhibition does not affect binding and fiber loss, but delays the kinetics of endocytosis 
a) Binding is intact. Unpermeabilized cells treated 4h with 25 µM Ami were either stained for surface CAR 
or exposed to  HAdV-C5-Atto488 for 1h at 4°C to allow virus binding and analyzed by flow cytometry. 
b) A time course of fiber release in a cold-synchronized infection was performed. Fixed cells were stained 
with R72 anti-fiber antibody and processed for confocal microscopy. The intensity of the antibody staining 
on the position of the viruses in a single cell-based analysis was determined. 
c) Endocytosis is delayed. A time course of endocytosis following a cold-synchronized infection with HAdV-
C5-Atto565 was performed. Surface viruses were recognized by incubation at 4°C with the 9C12 anti-hexon 
antibody in unfixed, unpermeabilized cells. The particles positive for Atto565 but negative for 9C12 staining 
were considered endocytosed. The % of endocytosis per cell was evaluated by confocal microscopy and 
Matlab. 
d,e) bSMAse accelerated endocytosis of HAdV-C5-Atto565 and TS1-Atto488. Endocytosis was evaluated as 
described in c.  Cells treated with Ami or untreated were exposed to HAdV-C2-Atto565 at 4°C. Warm 
medium supplemented with Ami, 0.012 U/ml bSMase or bSMase mixed with a 150-fold excess of its in vitro 
substrate HMU-PC was added to cells for 5 min at 37°C. Endocytosis of TS1 was evaluated at a time point of 
10 min. Scale bar=5 µm. 
f) Endosomal escape is reduced. At a time point of 20 min of  infection, when all viruses were internalized, 
the number of viruses at the PM, in endosomes or in the cytosol per cell were counted by EM. 
g) The SLO assay (Fig. 2b) does not allow distinction between surface and cytosolic virus. Therefore, surface 
HAdV-C5-Atto565 viruses were stained with the anti-hexon antibody 9C12 in parallel, unpermeabilized 
samples. Most viruses were internalized at the moment of SLO treatment. 
h) The delay in endocytosis and endosomal escape affects infection levels during 16h of continuous 
infection. However, the infection levels after 16h of a cold synchronized infection were not affected by Ami 
treatment.  
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Figure S3: HAdV-C2/5 but not Ts1 induced Ca2+-dep. lysosomal exocytosis to enhance endocytosis and 
escape 
a,b) The supernatants of cells exposed to a synchronized infection with the indicated ligands were collected 
after 15 min and 45 min for HeLa Ohio and Wi38 respectively (the kinetics of HAdV-C2/5 endocytosis in 
Wi38 cells is slower compared to HeLa Ohio, data not shown). The enzymatic activity of the released 
lysosomal ASMase and cytosolic LDH was evaluated. 
c) Cells were loaded with fluorescent lysotracker, then infected and subjected to live imaging. The intensity 
of the lysotracker signal per cell was determined at 0 and 20 min post-infection. The  ratio of the signal at 
20 min over 0 min is shown. 
d) Infection of HAdV-C5_EGFP  placed in medium devoid of extracellular Ca2+ for 2 h and subsequently in 
normal medium for 14 h was reduced. Virus binding w/wo calcium was equally efficient (data not shown). 
e-f) Endocytosis of HAdV-C5-Atto565 but not of TS1 is delayed in absence of extracellular Ca2+. Viruses were 
cold-bound to cells in full medium. Unbound viruses were washed away in media w/wo calcium. The time 
course of infection was performed in medium w/wo calcium.  
g) The SLO assay (Fig. 3d) does not allow distinction between surface and cytosolic virus. Therefore, surface 
HAdV-C5-Atto565 viruses were stained in parallel, unpermeabilized samples with 9C12. Most viruses were 
internalized at the moment of SLO treatment. 
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Figure S4: Incoming, uncoating competent HAdV induces cytosolic calcium transients that depend on 
extracellular calcium 
a-d) HeLa Ohio cells expressing the cytosolic calcium sensor GCamp5G were infected with the indicated 
HAdVs in medium w/wo either extracellular calcium or propidium iodide. Confocal time-lapse imaging was 
performed and the cytosolic signal intensity profile is shown. 
e) Uncoated HAdV-C2 causes permeability to PI in a VI-dependent manner. An additional quantification of 
PI intensity from Fig. 3i is shown. The neutralization of VI with a specific antibody reduced cell permeability 
to PI. 
f) Endocytosis is not a pre-requisite for cytosolic calcium transients. HeLa Ohio cells expressing Dyn2K44A-
GFP, a dominant negative dynamin-2 mutant incapable of vesicle scission, were imaged by time-lapse 
confocal microscopy in presence of propidium iodide. The expression of Dyn2K44A-GFP was reported to 
allow fiber shedding but block endocytosis (Nakano et al., 2000). The influx of PI was visualized, suggesting 
that virus uncoating but not endocytosis trigger these events. All scale bars are 10 µM. 
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Figure S5: bSMase rescues endocytosis in a dose-dependent manner 
a) A titration curve with bSMase was performed and the activity of ASMase released from cells infected 
with HAdV-C2 (like for Fig. 2a) was evaluated. 
b) Endocytosis of HAdV-C5-Atto565 in amitriptyline treated cells was rescued by supplementing the media 
with a concentration of bSMase similar to what is released during infection (Fig. S5a) for 5 min. A 10-fold 
higher/lower concentration did not enhance endocytosis.  
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DISCUSSION  
Early remodeling of the host lipid landscape 
Cellular lipids are essential at various stages of the viral life cycle. While several viruses actively remodel 
membranes during replication and egress, for binding and invasion they are thought to depend on the pre-
existing lipid landscape (Mazzon and Mercer, 2014). Previous lipidomic analysis revealed a profound 
reprogramming of host lipid metabolism during influenza (Tanner et al., 2014) and dengue virus (DENV) 
infection (Perera et al., 2012) at the earliest time point of 12h and 36h respectively. Interestingly, the entry 
process of UV treated, replication incompetent DENV is sufficient to alter cellular lipid landscape (Perera et 
al., 2012). Still, it is difficult to identify the function of such changes: they might support virus entry or be 
part of a cellular  antiviral response. Here, we provide a snapshot of the lipid landscape during the first 30 
min of virus infection. We found that infectious HAdV-C2 actively remodeled the host lipid landscape and 
intriguingly, over the 159 lipids profiled, only few ceramide species were selectively increased. Notably, 
entry of the mutant Ts1 did not trigger ceramide increase, indicating that this phenomenon is specific for 
uncoating competent adenovirus. All in all, we report the novel finding that HAdVs modulate specific lipid 
pathways already from the first minutes of interaction with the host. 
ASMase in infection 
Perturbation of selected ceramide generating pathways revealed that early ceramide increase supports 
infection and is mediated by acid sphingomyelinase. Acid sphingomyelinase facilitates the infection of 
several pathogens, including  Japanese Encephalitis virus (JEV) and Ebola virus (Avota et al., 2011a; Grassmé 
et al., 1997; Grassmé et al., 2003; Grassmé et al., 2005; Miller et al., 2012; Steinhart et al., 1984; Tani et al., 
2010). Infection levels of the enveloped JEV and Ebola virus are reduced by drug inhibition of cellular 
ASMase. Interestingly, addition of exogenous bSMase to the culture medium enhances JEV in Huh-7 (Tani 
et al., 2010), but inhibits Ebola virus infection in HeLa cells (Miller et al., 2012). This discrepancy suggests 
multiple functions for ASMase in infection.  
Lysosomal ASMase is a key factor in maintaining lipid homeostasis and membrane trafficking. It is 
conceivable that by exerting its constitutive function, ASMase provides a membrane environment 
permissive for virus infection. Alternatively, an imbalance of SM/CER on cell membranes might interfere 
with PM biophysical integrity and signaling properties. Along this line, surface bSMase inhibits Hepatitis C 
(HCV) infection in Huh-7 cells by enhancing internalization of the surface entry factor CD-81, thus by 
modulating PM dynamics (Voisset et al., 2008). 
Ceramide in endosomal escape: a role for membrane deformation and specific 
binding to VI? 
Ceramide facilitated VI exposure on endocytosed viruses and supported membrane penetration in vitro and 
in vivo. Notably, VI preferentially bound to enriched ceramide containing liposomes. Reduced VI exposure 
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on endocytosed viruses might indicate a role for ceramide in viral uncoating, already during PM events. 
CAR-directed surface driftings and binding to immobile integrins lead to mechanical shedding of fibers 
(Burckhardt et al., 2011). SM/ceramide enriched domains might influence these dynamics, and identical 
kinetic of fiber release was observed by immunofluorescence during ASMase inhibition (Fig. S2b). Since the 
fiber release assay by immunofluorescence has a low dynamic range, further investigations are needed to 
determine if ceramide does influence the shedding of the fibers. Based on our observation that VI binds 
preferentially to ceramide-containing liposomes than ceramide-free liposomes, it is likely, however, that 
surface ceramide stabilizes the binding of VI to the plasma membrane.  
 
Membrane permeabilization as a consequence of membrane deformation 
Membranes are often referred to as inert bilayers that are subjected to active modifications by proteins 
and passively accommodate the formation of pores. Yet, the biophysical properties of lipids and the 
dynamic nature of the membrane itself are factors that cooperate with proteins and influence the poration 
process (Wimley, 2010). Membrane responses to interferences by proteins are governed by 
thermodynamic principles and maintain the most favorable energetic state. 
 
A role for membrane curvature 
Strong membrane curvature can lead to leakage events. Several membrane penetrating peptides either 
preferentially bind to curved membranes, or actively induce membrane curvature. The induction of highly 
positive or negative curvatures favors the binding of pre-amyloid amphiphiles such as islet amyloid 
polypeptide IAPP (Smith et al., 2009), Aβ (Matsuzaki and Horikiri, 1999) and α-synuclein (Middleton and 
Rhoades, 2010), the AMPs magainin 2 (Matsuzaki et al., 1998b) and LL-37 (Henzler-Wildman et al., 2004), 
the CPP HIV TAT (Mishra et al., 2011), as well as the α-helical VI of adenovirus (Maier et al., 2010). During 
the transition from a disordered state to an amphipathic structure, the peptide shapes the membrane to fit 
its geometry. Membrane distortion in turn causes an energetically unfavorable rearrangement of the lipid 
landscape.  To resolve such membrane deformations, a possibility is the flipping of phospholipids from a 
leaflet to the other, a process that offers the opportunity of leakage events (Last et al., 2013).  
In endosomes, ceramide might play a role alone in destabilizing membranes by its virtue of inducing 
membrane curvature. As shown in Fig. 2h, bSMase incubation with liposomes triggered leakage of the 
liposomes also in absence of viral proteins. Natural ceramides have an inverted cone shape given by the 
two long hydrophobic tails and a very small polar head (Goñi and Alonso, 2006). Assembly of ceramides 
leads to the negative curvature of the leaflet where they are inserted. Spontaneous flip-flop of ceramide is 
possible but occurs at low rates (estimated rate: 22 min; Bai and Pagano, 1997). Instead, this possibly leads 
to the spontaneous flip-flop of phospholipids, and consequently to membrane leakage event. 
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A role for membrane tension 
SM conversion to ceramide increases surface area and membrane tension (López-Montero et al., 2007). 
While the PM benefits from exocytosis/endocytosis and cytoskeletal pulling forces to equilibrate 
membrane deformation (Groulx et al., 2006), endosomes might be more vulnerable and prone to poration. 
The membrane lytic factor of parvoviruses for example exploits uniquely lipid remodeling to induce 
membrane curvature and trigger endosomal escape (Farr et al., 2005; Filippone et al., 2008; Stahnke et al., 
2011; Zádori et al., 2001). The membrane lytic factor of Rotaviruses increases membrane curvature and 
endosomal surface tension (Abdelhakim et al., 2014). As a consequence of membrane tension,  membrane 
poration likely occurs. Unperturbed membranes are stable and the formation of pores is a highly 
unfavorable event. However, when external perturbations increase membrane tension, the spontaneous 
generation of pores becomes energetically favorable. Such perturbations include the binding of 
amphipathic peptides. The hydrophobic sides of the peptides initially displace the head groups of the lipids 
to access the core of the membrane. If the lipid tails are not simultaneously expanded (Huang et al., 2004; 
Lee et al., 2004), acyl chains are forced into an unfavorable packaging, which leads to surface tension (Lee 
et al., 2004). In this context, the formation of pores decreases the membrane surface area, allows lipids to 
return to the initial conformation and thereby ultimately releases the membrane tension. The energetic 
penalty of pore formation is therefore strongly decreased by the presence of membrane bound peptides. 
Biophysical studies of pore forming peptides interacting with liposomes allowed the modeling of a common 
principle for several poration mechanisms proposed by Last, Schlamadinger and Miranker: 
 
 
 
Fig. 5: Schematic representation of the energetic landscape during membrane poration.  
(i) In these energetic considerations, the intact phospholipid bilayer is considered as a 
reference point. (ii) Spontaneous thermal fluctuations have marginal impacts long as they 
remain below kT. (iii) Additional energy is required to extend membrane defects leading to 
membrane rupture. (iv) The partitioning  of amphipathic proteins onto the surface of the 
lipid bilayer induces membrane tensions and increases the occurrence of membrane defects 
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(v). Stochastic and transient pores form spontaneously to relax the surface tension. If small 
enough, they immediately reseal. In other cases, pores further assemble and grow (vi). (vii) 
Finally, some peptides are capable of stabilizing the rim of the pores. Thereby a full release 
of membrane tensions and further drop of the global energy level occurs. (Last et al., 2013) 
 
The energetic aspect of pore formation has been mathematically described in model lipid bilayers: 
𝐸𝑃 = 𝛾2𝜋𝑅 − 𝜎𝜋𝑅
2 
where 𝐸𝑃 is the energy of pore formation, 𝑅 is the radius of the pore, 𝜎 is the membrane tension and 𝛾 is 
the line tension. The line tension opposes pore formation and results from the attraction between 
hydrophobic groups at interphase between aqueous and hydrocarbon phase (Israelachvili et al., 1980; 
Taupin et al., 1975). Notably, the increase of one single parameter, the membrane tension 𝜎, is sufficient to 
trigger spontaneous pore formation. 
 
To summarize, according to this model membrane permeabilization does not require specific protein 
sequences that bind to specific lipids in a “key-lock” fashion. Instead, it fully relies on the amphipathic 
nature of the peptides and their capacity to induce membrane changes. Membrane tension is the primary 
and only trigger that renders membrane permeabilization energetically favorable. Also, the tension 
resulting from the binding of various peptides to a single membrane has additive effects. As a result, the 
peptides cooperate in the process of tension-induced membrane permeabilization without the need to 
oligomerize into pore structures. 
 
Of note, VI itself induces membrane positive curvature (Maier et al., 2010) and ceramide enrichment in the 
inner leaflet of endosomes induces membrane outward budding. VI and ceramide might therefore 
cooperate in destabilizing endosomes by a cumulative effect of independent membrane curvature and 
tension induction. Indeed, our in vitro liposome studies showed enhanced leakage when VI was exposed to 
ceramide-enriched liposomes. 
 
Specific binding of VI to ceramide 
EM analysis suggested that VI bound better to ceramide-containing liposomes than ceramide-free 
liposomes, indicating a specific ceramide-VI interaction. VI associates to membranes in a planar fashion 
(Maier et al., 2010). Accessing the hydrophobic core of the membrane implies that the hydrophilic heads of 
several lipids have to be displaced (discussed in the introduction). It is tempting to imagine that the 
lipophilic side of VI more easily displaces the small hydroxyl-head of ceramides compared to the 
phosphorylcholine-head of PC and SM. Also, VI preferentially binds to a sphingoid-backbone compared to a 
glycerol-based lipid, as suggested by the increased binding to SM compared to PC (Fig. 2e,f).  
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Fig. 16:  structure of the PC, CER and SM species used in this study (Avanti). The head group of the lipids is 
highlighted. Red indicates phosphorylcholine and green the hydroxyl-group. 
 
Efficient VI binding increments the protein/lipids ratio and might enhance membrane permeabilization 
events by carpet model (described in the introduction). That the protein/lipid ratio is critical in such events 
was previously shown for several membrane lytic factors, including the AMPs cecropin A, melittin and 
gamma of FHV (Maia et al., 2006; Shai, 1999). These factors share with VI a short alpha-helical domain, 
amphipathic properties and planar association to membranes (Last et al., 2013; Maier et al., 2010). 
Similarly to VI, gamma has been shown to efficiently permeabilize liposomes with specific lipid 
compositions and low cholesterol (Maia et al., 2006). Analogous effects were seen for other AMPs (Mason 
et al., 2007; Nicol et al., 1996; Won et al., 2012), suggesting that membrane composition influences the 
efficiency of permeabilization. 
 
Ceramide might also dictate the modality by which VI perforates membranes. Magainin 2 and melittin 
switch from detergent-like permeabilization to the formation of stable pores depending on membrane lipid 
composition (Ladokhin and White, 2001; Lee et al., 2008; Ludtke et al., 1996). Recombinant VI aggregates in 
solution (personal communication, M. Suomalainen), yet to our knowledge VI assembly into pore-
structures has never been characterized. Together, these findings emphasize how membrane composition 
can influence protein mediated leakage. 
 
VI might carry a specific binding site to ceramide or its sphingoid base. Previous studies identified a 
sphingomyelin binding motif conserved in the transmembrane (TMD) domain of several integral membrane 
proteins (Björkholm et al., 2014; Contreras et al., 2012). SM 18 specifically binds to the TMD of p24 but not 
p23, two proteins involved in COPI vesicle budding in the Golgi. The binding involves both head group and 
backbone of SM, and is of higher affinity towards SM 18 compared to for example SM 16, SM 20, PC 18 and 
CER 18. Crucial for this is the signature sequence VXXTLXXIY. VXXTL packs the C18 chain and mutation of L 
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completely abrogated binding to the lipids, while Y interacts with the polar head of SM (Contreras et al., 
2012). VI of HAdV-C5 partially shares this signature: WXXTLXXIV (position 229-237, Uniprot annotation: 
Q2KS09). This signature is highly conserved among human adenovirus species and groups. Tryptophane (W) 
has a considerably bigger side chain than valine (V), but it is as well hydrophobic and might therefore still 
interact with the hydrocarbon chain of sphingolipids. Studies with mutant VI attributed the full capacity of 
membrane lysis to the N-term amphipathic domain, but sphingolipids were never included in the synthetic 
membranes used for the in vitro experiments (Maier et al., 2010). Moreover, studies with mutants are 
difficult, as the VI sequence 231-242 contains a nuclear localization signal, essential for nuclear import of 
newly synthesized hexons during viral assembly (Wodrich et al., 2003). 
 
We can propose a speculative two step model of VI interaction with ceramide: first, the low polarity of the 
ceramide head group facilitates adsorption of the N-term amphipathic-alpha helix in a planar fashion.  
Second, the sphingoid backbone offers the opportunity of inserting the C-term domain of VI into the bilayer 
by high affinity binding. The determination of tryptophan depths into membranes containing ceramide 
might clarify whether VI insertion indeed occurs. 
 
Changes in the curvature of the endosomal membrane, leakage events or altered lipid composition might 
be sensed by cytosolic proteins and attract cellular machineries that further contribute to efficient escape. 
The ESCRT protein CHMP4B immediately localizes to lysed PM (Jimenez et al., 2014), SphK associates with 
ceramide-rich endocytosed structures (Shen et al., 2014), and galectins cluster on ruptured membranes 
(Martinez et al., 2013). Yet, although bSMase treatment enhanced TS1 endocytosis, it was not sufficient to 
rescue TS1 escape. Together with the observation that TS1 does not efficiently shed its fibers and does not 
expose protein VI, this observation underlines the importance of viral uncoating and a cooperation 
between lipids and viral factors in coordinating membrane lysis. 
 
For HAdV-C2/5, we propose a multistep endosomal leakage process. Ceramide-induced membrane 
curvature and tension combined with occasional VI binding to membranes triggers minor leakage events 
(phospholipids flip-flop, spontaneous and short-lived membrane poration) that initially interfere with 
endosomal osmotic balance and render endosomes fragile. Next, further capsid uncoating and full VI 
exposure locally generate high concentrations of proteins that efficiently bind to ceramides. In the context 
of a small, highly curved endosome devoid of the stabilizing clathrin coat, this triggers the final leakage 
event and permits the escape of a 90 nm capsid. 
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PM permeabilization triggers calcium-dependent lipid remodeling 
Intriguingly HAdVs actively modified the lipid landscape to ensure ceramide production in host membranes. 
Early release of VI by incoming HAdVs transiently permeabilized the plasma membrane to trigger calcium-
dependent lysosomal exocytosis and delivery of ASMase to the cell surface. ASMase exocytosis was 
previously observed for other pathogens, such as rhinovirus (Grassme et al., 2005; Grassmé et al., 2005), 
measles virus (Avota et al., 2011b), Neisseria gonorrhoe (Grassme et al., 1997), and Pseudomonas 
aeruginosa (Grassme et al., 2003). Incoming rhinovirus and measles virus cause the formation of PM 
ceramide-enriched domains to which viruses co-localized. However, this was visualized by 
immunofluorescence and concerns regarding specificity of the ceramide antibody and reliability of fixations 
techniques have been raised (see introduction). HRV binding and the activation by measles virus of surface 
cell signaling via DC-SIGN on dendritic cells or an unidentified factor on T-cells (Gassert et al., 2009) were 
the trigger for ASMase re-localization (Dreschers et al., 2007; Grassme et al., 2005). During HAdV entry, the 
key stimulus was unexpectedly direct plasma membrane permeabilization. That HAdVs induce PM 
permeabilization was previously suggested (Di Paolo et al., 2013; Wickham et al., 1994). Studies in artificial 
systems where viruses were blocked at the cell surface and acidified, initially identified penton base as the 
lytic factor (Seth, 1994; Wickham et al., 1994). In these studies the readout for membrane permeabilization 
was the  release of radioactive choline from either cells or liposomes. Antibodies against penton base (Seth, 
1994) or soluble penton base (Wickham et al., 1994) blocked membrane permeabilization. Another possible 
interpretation of these results is that blocking penton base prevents viral uncoating. As a consequence, VI is 
not released and membrane lysis can not occur.  
How to harness calcium signaling? 
PM permeabilization resulted in cytosolic influx of extracellular calcium. Calcium is a ubiquitous and highly 
versatile ion sensed by a wide variety of cellular factors. Within the lifetime of an organism, it is not 
degraded. To control its activity, the cell compartmentalizes calcium ions and expresses for example 
proteins that carry functions depending on calcium binding. Calcium is involved in the regulation of 
fundamental biological processes such as fertilization, proliferation, development, learning and memory, 
contraction and secretion (Berridge et al., 2000). It is not surprising that calcium signaling is harnessed by a 
variety of viruses at different replication stages. Adenovirus itself was already known to depend on 
extracellular calcium for virus uptake and penetration (Greber et al., 1997; Nemerow and Stewart, 1999; 
Wu et al., 2006). 
Calcium homeostasis is tightly regulated; extracellular calcium concentrations are around 1 mM, cytosolic 
calcium concentrations are kept at approximately 100 nM and ER stores contain about 100 µM Ca2+ 
(Syntichaki and Tavernarakis, 2003). In this work, we showed that incoming HAdVs induced short-lived 
calcium transients and PI influx. This indicated minor lesions that spontaneously resealed, or were 
efficiently repaired.  
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How are small lesions formed? Surface events during adenovirus entry, such as the binding of integrins to 
penton base, lead to the clockwise untwisting of the penton base (Lindert et al., 2009) and partial 
uncoating. Disassembly of the first vertices likely allows release of few copies of VI. The release of just a few 
molecules of VI from multiple vertices may lead to a local high concentration of VI on the membrane, and 
possibly transient membrane lysis. Considering that the extracellular calcium concentration is about 10'000 
fold higher than intracellular, even short-lived PM lesions offer the opportunity of a dramatic increase in 
cytosolic calcium. Calcium increase might be locally limited, but still sufficient to trigger the fusion of PM 
proximal lysosomes (Jaiswal et al., 2002). 
 
Similarly to HAdV, other viruses induce calcium transients during entry. Coxsackie virus B (CVB), a non-
enveloped virus that binds to CAR, induces a depletion of intracellular calcium stores. This occurs via virus 
mediated clustering of the Decay Accelerating factor (DAF), and subsequent activation of Src, PLC and Ins3P 
signaling. CVB exploits calcium signaling to activate calpain and thereby promote intracellular virus 
trafficking (Bozym et al., 2010). Influenza induced calcium transients very early after binding to cells, by 
unknown mechanisms that involve release of ER calcium stores. Cytosolic calcium transients initiate a 
positive-feedback loop that activates Rho- and Ras-signaling for efficient endocytosis (Fujioka et al., 2013). 
HSV entry showed a two-step regulation of calcium fluxes. First, virus binding to syndecan-2 and nectin-1 
and shifting cells to 37°C increased PM calcium levels. Second, an αvβ integrins-dependent signal and Akt 
activation triggered the release of calcium from the ER (Cheshenko et al., 2007; Cheshenko et al., 2013).  
Different viruses harness calcium signaling by multiple strategies that converge into the instantaneous 
enhancement of endocytosis, and Ca2+-dependent lipid remodeling might be a common feature. 
 
Immediate consequences of calcium influx depend on amplitude, duration and localization of such event. 
The bacterial pore forming toxin SLO rapidly induces lysosomal exocytosis and consequent endocytosis of 
the lesions (Idone et al., 2008; Tam et al., 2010), but also triggers the formation of PM blebs. The blebs 
might contain lesions and can be shed extracellularly via an annexin-5 dependent mechanism (Babiychuk et 
al., 2009; Keyel et al., 2011). Similar blebbing phenotypes are also observed after laser-mediated PM 
damage, and involves ESCRT components (Jimenez et al., 2014). Cellular responses to HAdV infection find 
agreement with both conflicting observations. Short-lived lesions did not affect cell morphology and 
survival, but when openings failed to be resealed, events of membrane blebbing were visualized. While 
bacterial toxins mostly form stable, long-lived pores with dramatic consequences on cell survival 
(Bischofberger et al., 2012), HAdVs finely control PM integrity to induce selected PM repair mechanisms, 
but avoid detrimental lesions. 
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Immediate consequences of PM permeabilization? 
The multiple downstream effects of calcium signaling might include the activation of p38/MAPK pathway. 
Incoming HAdV, but not TS1, induces calcium influx (Fig. S4a) and activates p38/MAP kinase by mechanisms 
independent of integrins signaling (Suomalainen et al., 2001; Tibbles et al., 2002). Activation of p38 
facilitates nuclear targeting and the adenoviral nuclear life (van der Houven van Oordt et al., 2000). Of 
note, most pore forming toxins, besides inducing calcium influx also activate p38 (Porta et al., 2011). 
Similarly, PM permeabilization might be the underlining mechanism for p38 activation by HAdV. A direct 
correlation between these events might be addressed in the future. 
P38 signaling has recently been related to ASMase activity. ASMase inhibition with an amitriptyline 
analogue abrogated activation of p38 as well as IL-6 synthesis and release (Perry et al., 2014). Incoming 
adenovirus is known to rapidly induce IL-6 release, together with a cocktail of other cytokines. When 
released by infected macrophages, these cytokines act in favor of infection, by re-localizing integrins to the 
apical surface of polarized epithelial cells (Lütschg et al., 2011). Therefore, targeting ASMase in a natural 
infection might be anti-adenoviral at two levels: first by confining entry receptors to the basolateral side of 
the target tissue and second by inhibiting endocytosis, escape and infection. However, the involvement of 
ASMase in releasing inflammatory cytokines during a natural infection remains controversial, as ASMase-/- 
mice were shown to efficiently secrete IL-1beta, IL-6, TNF and IFN-gamma (Manthey and Schuchman, 1998; 
Utermöhlen et al., 2003). Also, precise kinetics of p38 activation and which p38 isoforms are involved 
remains to be characterized. 
 
Ceramide in endocytosis, biophysical or signalling role? 
Exogenous bacterial sphingomyelinase readily increased cellular ceramide levels and rescued HAdV-C2 
endocytosis in amitriptyline treated cells (Fig. 2i, S2 d). Ceramide might favor endocytosis for two reasons, 
by inducing membrane inward budding or clustering PM signaling factors.  
Although the abundance of ceramide in membranes is low (Castro et al., 2014), ceramide profoundly 
impacts the biophysical properties of membranes. Ceramides influence lateral segregation of membrane 
factors, tend to aggregate and induce membrane curvature, provoke inward budding and support 
membrane permeabilization. Few but crucial reports highlighting these features were selected among a 
copious literature and are briefly discussed here. Studies employing bacterial sphingomyelinase (bSMase) 
to generate ceramide from sphingomyelin were preferred over studies using synthetic ceramides. 
An influence of ceramide on membrane partitioning was initially observed in model membranes by Ira and 
collaborators (Ira and Johnston, 2008). In these experiments, the fluorescent compound TR-DHPE was used 
as a marker for the fluid phase and cholera-toxin B-647 was employed to detect GM1 containing rafts. The 
acquisition of the samples was done by TIRFM and AFM. When bSMAse was added to the supported 
bilayers, the segregation of the membrane markers into platforms rapidly occurred (Ira and Johnston, 
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2008). In a similar assay, Chiantia and colleagues demonstrated that the partitioning of proteins interacting 
with membranes, such as synaptobrevin2 and GPI-PLAP was differentially regulated in synthetic lipid 
bilayers (DOPC, cholesterol, CER) containing increasing ceramide levels (Chiantia et al., 2008; Christensen et 
al., 1988).  
Lateral segregation induced by ceramide in biological membranes was recently investigated by Pinto and 
colleagues (Pinto et al., 2014). To mimic physiological conditions, ceramide was produced via 
sphingomyelin hydrolysis by bSMase. Ceramide production was measured by TLC and occurred very rapidly, 
within 0 to 5 min post incubation of HEK cells with bSMase. The segregation behavior of the anisotropy 
markers NBD-DPPE and t-PnA indicated that the level of order in membranes as well rapidly increased. 
Within 15 min of incubation the formation of gel-like domains was visualized. Since high concentrations of 
ceramide have been implicated in pore formation (Siskind et al., 2002), the authors addressed the integrity 
of the plasma membrane by lactate dehydrogenase (LDH) assay. Of note, HEK cells were intact during the 
course of the whole experiment indicating that bSMase alone was not capable to induce membrane 
permeabilization (Pinto et al., 2014).  
 
Ceramide association also influences membrane budding. Ceramide aggregates generated by bSMase 
might result in inward budding of membrane portions, as observed in model liposomes (Holopainen et al., 
2000; Trajkovic et al., 2008). Interestingly, Zha and collaborators observed that exogenous addition of 
bSMAse to endocytosis incompetent fibroblasts and macrophages (by deoxyglucose and sodium azide 
treatment) rescued the uptake of FITC-dextran. Results suggested a function for PM ceramide in inward 
budding of endocytic vesicles (Zha et al., 1998) independently of additional cellular factors. Ceramides 
support endocytosis also in unperturbed cell culture conditions. This was verified for cargos of various sizes 
that bound to different receptors. Cellular ASMase has been implicated in the phagocytosis of Neisseria 
gonorrhoeae (Hauck et al., 2000) and Neisseria menigitidis (Simonis et al., 2014) and in the uptake of 
polystyrene-beads targeted to ICAM-1 (Serrano et al., 2012).  
 
Endocytosis requires extensive membrane rearrangements, orchestrated by tight protein-lipid interactions 
(Doherty and McMahon, 2009). Lipid-regulated lateral segregation of membrane factors generate 
microdomains that coordinate protein localization and activity (Breslow and Weissman, 2010; Simons and 
Sampaio, 2011). SM is a major player in PM organization (Simons and Sampaio, 2011), is particularly 
enriched on the outer leaflet of the PM (Slotte et al., 1990) and about 10 times more abundant than 
ceramide (Bielawski et al., 2006). Visualization of nanoscale membrane domains revealed the co-existence 
of SM and PI(4,5)P2 (PIP2) (Abe and Kobayashi, 2014). PIP2 is enriched at sites of endocytosis and plays a 
fundamental role in the nucleation of clathrin-mediated endocytic pits (Doherty and McMahon, 2009). The 
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addition of bSMase triggered the dispersion of these SM domains (Abe and Kobayashi, 2014), suggesting a 
possible impact of ceramide increase in endocytic processes.  
Enhanced endocytosis might require generation of ceramide metabolites. For example, sphingolipid 
homeostasis is necessary for endocytic trafficking of rhodopsin and the integrity of photoreceptor cells in 
flies (Acharya and Acharya, 2005; Yonamine et al., 2011). In particular, ceramidase was shown to facilitate 
the endocytosis of the G protein receptor rhodopsin 1 (Acharya et al., 2004). Furthermore, S1P increased 
endocytosis of FITC-dextran in mature dendritic cells (Maeda et al., 2007). Remarkably, a sub-population of 
neutral ceramidases is found on the PM (Ito et al., 2014). Thus, following SM conversion to ceramide by 
bSMase, neutral ceramidases might readily convert ceramide into sphingosine. While ceramide flip-flop is 
rare, sphingosine can spontaneously switch lipid bilayer (Hannun and Obeid, 2008) and be metabolized into 
S1P by cytosolic sphingosine kinase. Indeed, sphingosine kinase is enriched on tubular endocytic structures 
triggered by bSMase (Shen et al., 2014). Unfortunately, the abundance of sphingosine and S1P in our 
samples was below the detection limit of the lipid profiling experiments. Further analysis are required to 
identify sphingosine and S1P requirements during infection. 
 
Intriguingly, S1P and ceramide have opposing roles in regulating the ERM proteins ezrin, radixin and 
moesin. The ERM proteins physically link the PM to the actin cytoskeleton and have been localized on 
clathrin coated vesicles (Barroso-González et al., 2009) and early/recycling endosomes (Harder et al., 1997; 
Morel and Gruenberg, 2009; Stanasila et al., 2006). By regulating vesicle trafficking (Cha et al., 2006; 
Tamma et al., 2005; Zhou et al., 2003), endosome maturation (Chirivino et al., 2011) and actin cytoskeleton 
dynamics (Adada et al., 2014), ERM proteins widely impact endocytic processes. Exposure of HeLa cells to 
bSMAse acutely inactivated ezrin via protein-phosphatase 1 (Canals et al., 2010), an event likely to occur 
also in our experimental conditions. How ERM tune adenovirus infection remains obscure, but their 
regulation by sphingolipids might be important for virus endocytosis. 
 
In addition, an increase of PM ceramide profoundly impacts cell signaling. The impressive variety of cellular 
processes affected by ceramide proposes a general role of ceramide in clustering membrane signaling 
factors (Kolesnick, Alonso 2000). Such clustering might involve factors required for endocytosis (Hauck et 
al., 2000; Serrano et al., 2012; Simonis et al., 2014). Yet, depletion of sphingomyelin without ceramide 
production might be sufficient to alter endocytic pathways. SM coalesce into PM rafts with cholesterol 
(Simons and Sampaio, 2011) and cholesterol depletion by methyl-beta-cyclodextrin (MβCD) phenocopies 
bSMAse treatment in terms of massive, tubular endocytosis (Shen et al., 2014). Cholesterol is required for 
membrane homeostasis, trafficking, or signaling during adenovirus endocytosis and escape (Imelli et al., 
2004). Of note, acute MβCD treatment also depletes SM (Giocondi et al., 2004). The acute depletion of 
cholesterol (50 mM MβCD, 20 min) employed during HAdV entry was reported to delay endocytosis. 
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Accordingly, an acute depletion of SM mediated by highly concentrated bSMase inhibited HAdV 
endocytosis (Fig. S5b). Also, a prolonged incubation with increasing bSMase concentrations interfered with 
HeLa cell survival (data not shown), in agreement with a role for ceramide in cell death (Obeid et al., 1993). 
Harsh perturbations have adverse consequences for virus entry, but what happens under 'physiological' 
conditions? For rescue experiments, we estimated the amount of ASMase released during HAdV-C2 entry 
(Fig. S5a), and observed that add-back of similar concentrations accelerated both HAdV-C2 and TS1 
endocytosis (Fig. S2d,e). Together, the available data highlight how ceramide potentially modulates HAdV 
endocytosis at multiple levels, including physical membrane curvature, initiation of endocytosis, 
segregation of signaling factors and as a substrate for other sphingolipids. 
Targeting ceramide metabolism: a clinical perspective  
Amitriptyline was introduced by Merck in the early sixties to treat depressive disorder (Beckmann et al., 
2014) and continues to be FDA-approved for this application. During this long clinical history, an extensive 
knowledge of pharmacokinetics, benefits and side-effects was gained and essentially documented the 
safety of this compound. Amitriptyline and other ASMase inhibitors meanwhile showed efficacy against 
cystic fibrosis and cardiovascular, metabolic, inflammatory, liver and infectious diseases (Beckmann et al., 
2014). Targeting ASMase could be a valid strategy against a broad number of pathogens. Yet, ASMase 
activity needs to be fine-tuned. Knockout of ASMase blocks phagocytosis and thereby confers high 
susceptibility to some bacterial infections (Utermöhlen et al., 2003). Also, too low ASMase activity in 
plasma leads to thrombus formation (Münzer et al., 2014). Moreover, long term ASMase inhibition is not 
conceivable as it would mimic Niemann-Pick disease symptoms. All in all, future developments in ASMase 
research might offer drugs for acute and highly specific ASMase inhibition. Administration by aerosol would 
specifically inhibit infectious diseases of the upper respiratory tract. Yet, although reduction of ASMase in 
lungs improved survival of CFTR patients (Becker et al., 2012), cells of the immune system might be less 
effective in survey (Utermöhlen et al., 2003) and activation of innate immunity responses such as 
inflammasome. Comprehensive lipidomics of infections in a physiological context, as previously done for 
influenza in mice (Tam et al., 2013b), might help clarifying the complexity of the lipid contribution to pro- 
and anti-viral events. 
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MATERIALS AND METHODS  
 
Cells and viruses: HeLa cervical carcinoma cells, subline Ohio (from L. Kaiser, University Hospital, Geneva, 
Switzerland) (Greber et al., 1993), human bronchial epithelial A549 cells, and primary human embryonic 
lung Wi-38 cells (both American Type Culture Collection) cells were grown at 37°C under 5% CO2 in 
Dulbecco's modified Eagle's medium (DMEM; Sigma) supplemented with 7.5% fetal calf serum (FCS; Life 
Technologies) and 1% nonessential amino acids (Sigma). Human Niemann-Pick disease A fibroblasts 
GM00112 (Coriell Institute for Medical Research (Camden, NJ) were cultured in Eagle’s Minimum Essential 
Medium with Earle’s salts, 1% non-essential amino acids and 10% fetal calf serum and human airway 
epithelial cells from nasal biopsies (hAECN) in hAEC medium (both Epithelix). HAdV-C2, the penetration-
deficient mutant TS1, and HAdV-C5 were grown in A549 cells, isolated, and labeled with Alexa Fluor 488 
(Alexa488; Life Technologies) or Atto-565 (Atto-tec, Germany) as previously described (Greber et al., 1996; 
Greber et al., 1993). HAdV-C5_EGFP, an E1/E3 deletion mutant virus containing the enhanced green 
fluorescent protein (EGFP) gene in the E1 region under the control of cytomegalovirus major immediate 
early promoter (Fleischli et al., 2007; Nagel et al., 2003) and the HAdV-C5_EGFP-VI_L40Q (VI-L40Q) (Moyer 
et al., 2011) were grown in 911 cells. 
 
Lipid extraction and mass spectrometry: for lipid profiling, 8x106 HeLa Ohio cells were infected for 30 min 
with 6.8-ml inocula containing 2 µg of either HAdV-C2 or TS1. Total lipid extracts were collected according 
to a modified Bligh and Dyer protocol and quantitative analysis of lipids was performed by HPLC MS/MS. 
The detailed procedure is described in (Tanner et al., 2014).  The log2 fold change of lipid abundance at 0 
and 30 min pi is plotted. Statistical significance was evaluated by unpaired student’s t-test (two-tailed, 
p<0.05). For ceramide quantification in bSMase treated samples, 2x106 HeLa Ohio cells were incubated for 
5 min with 0.2 U bacterial sphingomyelinase from S. Aureus (bSMase; Sigma). Total lipid extracts were 
collected similarly to a previously described protocol (Guan et al., 2013). 0.75x106 cells were grown 
overnight in 6-cm plates. 0.2 U bSMase in 4 ml culture medium were incubated with cells for 5 min at 37°C, 
5% CO2 . For lipid extraction, cells were placed on ice and further processed with ice cold reagents. Cells 
were scraped in total 4 ml PBS and carefully re-suspended. 200 µl of cell suspension was used for cell 
counting with CASY (Roche) and determination of protein concentration (Micro BCA kit ; Thermo Scientific). 
Cells were centrifuged at 5’000 rpm for 5 min at 4°C, the pellet was re-suspended in 30 µl PBS, transferred 
into fresh 1.7 ml tubes (Axygen), shock-frozen and stored at -20°C until further processing. For lipid 
extraction,  600 µl of  chloroform : methanol 1 : 2 (chloroform: CHROMASOLV
® Plus, ref.: 650471-1L; Sigma) 
were added to the cell pellet. The suspension was vortexed 1 min and put on ice for 4 min. This step was 
repeated  in total three times, then 300 µl chloroform + 200 µl H2O were added. The samples were 
vortexed 30 sec and put on ice 1 min*, in total 3 times, before being centrifuged at 9’000 rpm for 5 min at 
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4°C. The lower phase containing lipids was pipetted into a clean tube with a 200 µl tip resistant to 
chloroform dissolution (ref.: 070000; Greiner Bio-One). Special care was taken in avoiding to contaminate 
the organic phase with the proteins and ions precipitates at the interphase. The aqueous phase was re-
extracted by adding 500 µl chloroform and repeating the procedure from*. The two organic phases were 
pooled and dried in the Speedvac (Thermo Scientific) at maximal 30°C. Samples were sealed and stored at -
20°C. Ceramide and sphingomyelin were quantified using LC-MS (Guan et al., 2013).  
 
Infection assays: Cells grown on 96-well imaging plates (Greiner Bio-one) were infected in DMEM-0.2% 
fatty acid free bovine serum albumin fraction V (FAF BSA; Roche) for 16-24 h to reach an infection level of 
20-40%. Cells were fixed, stained with DAPI and anti-VI (Burckhardt et al., 2011) or anti-hexon (mab 8052; 
Millipore) and imaged by automated fluorescence microscopy with ImageXpress Micro (Molecular Devices). 
Mean fluorescence intensity of the nuclear GFP signal and percentage of either GFP expressing or VI 
stained cells was evaluated using a custom programmed Matlab routine. For drug interference, cells were 
treated with 50 μM myriocin(He et al., 2004) (Enzo Life Sciences), 100 μM fumonisin B1 (Tocris; Wang et al., 
1991), 50 μM GW4869 (Luberto et al., 2002) , 25 μM amitriptyline (Kornhuber et al., 2008) and 5 μM 
fluoxetine (Kornhuber et al., 2008) (all Sigma) for 4h before and during infection with either HAdV-C5_EGFP 
or HAdV-C5. For siRNA mediated knockdown of ASMase, HeLa Ohio cells were subjected to reverse-
transfection with 10 nM siRNA using lipofectamine RNAiMAX (LifeTechnologies) and cells were infected 
after 72 h. ON-TARGET Plus siRNA sequences against human SMPD1 (J006676-05; J-006676-06) and Non 
targeting sequences were obtained from Thermo Scientific Dharmacon ; siRNA against GFP from 
Microsynth. For rescue experiments in GM00112 cells, inocula were supplemented with 0.024 U/ml of 
bacterial sphingomyelinase (bSMase) from S. Aureus (Sigma). For calcium-free infection assays, cells were 
exposed to the inoculum w/wo calcium (lysosomal exocytosis buffer) for 2h, then placed for further 14h 
into DMEM-0.2% FAF BSA to avoid cell detachment.                
    
Fiber loss, endocytosis and VI exposure: fluorescently labeled HAdVs were exposed for 1h at 4°C to cells 
pre-treated for 4h with 25 µm Ami or DMEM-0.2% FAF BSA, to yield 50-200 viruses per cell. Bound viruses 
were internalized at 37°C for the indicated time. For rescue experiments, medium was supplemented with 
either Ami, 0.012 U/ml bSMase or bSMase mixed with a 150-fold excess  of its in vitro substrate HMU-PC 
and added to cells for 5 min at 37°C. For the endocytosis assay, surface viruses were stained with 9C12 anti-
hexon antibody (Varghese et al., 2004) at 4°C in intact cells. For fiber loss and VI exposure, fixed and 
permeabilized samples were stained with R72 anti-fiber antibody (Baum et al., 1972) and anti-VI antibody 
(Burckhardt et al., 2011). Samples were processed for fluorescence microscopy and images acquired with 
Leica SP5 equipped with 63×objective (oil immersion, numerical aperture 1.4). Maximum projection images 
of Z-stacks (11x 0.5 μm steps, 16× frame averaging) were analyzed using a customized Matlab routine 
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(available upon request). Fluorescence intensity of the antibody staining on the position of each virus was 
determined and mean values per cell are shown. Endocytosed viruses were identified as positive for the 
fluorescent tag but negative for surface staining with 9C12. Intensity of VI staining was evaluated on 
endocytosed viruses only, to exclude effects due to internalization delay. For further details, please refer to 
(Burckhardt et al., 2011; Suomalainen et al., 2013). 
Detection of cytosolic viruses: cytosolic viruses were distinguished from endosomal viruses using SLO-
penetration assay and EM analysis. Both procedures were performed exactly as described in (Suomalainen 
et al., 2013). Briefly, cells were pre-treated for 4h with 25 µm Ami or 1h 10 µM nocodazole or left 
untreated and exposed to a cold-synchronized infection for various times. For rescue experiments, medium 
was supplemented with either Ami, 0.012 U/ml bSMase or bSMase mixed with a 150-fold excess  of its in 
vitro substrate HMU-PC and added to cells for 20 min at 37°C. For SLO-assay, streptolysin O (SLO; kindly 
provided by M. Husmann and S. Bhakdi, University Medical Center, Johannes Gutenberg-University Mainz) 
was used to selectively permeabilize plasma membranes and allow perfusion of antibodies to the cytosol 
but not to the lumen of intracellular organelles. HAdV-C5-Alexa488 and TS1-Alexa488 were immuno-
stained for 1h at 4°C with rabbit anti-Alexa Fluor 488 antibodies (Life Technologies). Samples were 
processed as described in the previous section. Mean signal intensities of anti-Alexa Fluor 488  associated 
to viruses per cell are indicated. For quantification of EM sections, the number of viruses at the plasma 
membrane, in endosomes and in the cytosol was determined by manual counting (K. Boucke, IMLS Zürich). 
 
Liposome floatation: 1-palmitoyl-2-oleoylphosphatidylcholine (PC), N-octadecanoyl-D-erythro-sphingosine 
(CER), N-octadecanoyl-D-erythro-sphingosylphosphorylcholine (SM) and extruder were obtained from 
Avanti Polar Lipids. Lipids were dissolved in ice cold chloroform as indicated in Table 2 and conserved at -
20°C in sealed glass containers. 
 
Lipid Full name Origin Product nr. Amount (mg) Vol. (ml) Conc. (mg/ml) 
PC 
(16:0/18:1) 
1-palmitoyl-2-oleoyl-
sn-glycero-3-
phosphocholine 
Synthetic 850457P 25 3.78 6.6 
SM  
(mainly C18) 
N-octadecanoyl-D-
erythro-
sphingosylphosphoryl
choline 
Brain, 
porcine 
860062 25 3.43 7.24 
Cer  
(mainly C18) 
N-octadecanoyl-D-
erythro-sphingosine 
Brain, 
porcine 
860052P 25 5  5 
 
Table 2: informations concerning the lipids ordered by Avanti used in this study are summarized. 
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Lipids were mixed as indicated in table 3 and dryed in a Speedvac (Thermo Scientific). To avoid plastic 
contaminations in the samples, tubes and tips resistant to organic solvents were exclusively employed 
(Axygen and Greiner Bio-One). Dried lipid films composed of PC, PC:CER 99:1 mol% and PC:SM 99:1 mol% 
were hydrated in liposomes buffer (10 mM Hepes, 150 mM NaCl, 2 mM CaCl2, pH 7.5) to a final 
concentration of 1 mg/ml. Ceramide and sphingomyelin containing samples were hydrated by incubation in 
the water bath at 42°C and vortexing. To achieve an homogeneous size of the liposomes and mimic 
endosomal dimensions, lipid suspensions were subjected to 20 freeze-thaw cycles and extruded 11 times 
through a 100 nm polycarbonate-membrane (Avanti). Liposomes suspensions were shock-frozen and 
stored at -20°C. 
Mol % POPC (µl of a 6.6 mg/ml stock) Cer (µl of a 0.5 mg/ml stock) SM (µl of a 0.724 mg/ml stock) 
100/0/0 151.5 - - 
99/1/0 150 37 - 
99/0/1 150 - 27 
 
Table 3: lipid mix to prepare 1 ml of 1 mg/ml liposomes. The stock solutions were prepared as  
indicated in table CC, except for cer and SM that were further diluted 1:10. 
Viruses were incubated 10 min at 45°C to induce uncoating (Wiethoff et al., 2005) (Fig. 2d). Uncoated 
viruses (4 µg) were incubated for 15 min at 37°C with liposomes (100 µg). Samples were put on ice and 
mixed with Optiprep (Sigma) to a final concentration of 15%. Each 600 μl sample was overlayed with a 
density gradient of Optiprep (1.5 ml of 10%, 1 ml of 2.5% and 0% in liposomes buffer, ice cold) and 
centrifuged at 100’000 g for 2h at 4°C. Low density, empty liposomes floated to the top fraction of the 
gradient, while liposomes bound to viral proteins concentrated into a lower band (Fig. 2c). Fractions (400 
μl) were immediately collected, subjected to immuno-gold labeling of VI and analyzed by EM negative 
staining with uranyl acetate. Images were acquired with magnification 25'000x, where the gold signal is 
indistinguishable. Each image was further magnified (80'000x) and the total number of liposomes and 
liposomes bound to gold were counted. To avoid underestimation of binding, when one liposome bound to 
n+1 gold, n liposomes with 100% binding (meaning one liposome bound to one VI-gold)  were included in 
the statistics. 
Liposomes leakage: Total lipid extracts of 5x106 HeLa Ohio cells were collected according to a modified 
Bligh & Dyer method (Tanner et al., 2014), dried and re-hydrated in 0.2M 6-carboxyfluorescein (6-CF; 
Sigma). Liposomes were produced as described for the liposome binding assay. To remove unincorporated 
6-CF, a 1 ml gravity flow column (Biorad) filled with Sephadex-G50 (Pharmacia Biotech; hydrated overnight 
at 4°C) and centrifuged 2 min at 2’000 g was used. 100 µl liposomes were loaded on the gel and centrifuged 
2 min at 2’000g. The eluate was further cleared by a second step of centrifugation on a new column and 
the final volume brought to 200 µl with liposomes buffer. For each new liposomes solution, linear range of 
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the leakage was first established. The concentration of viral proteins and bSMAse that induced 10-20% 
leakage were employed. Cleared liposomes (8-10 µl, resulting from approximately 5x104 cells) were 
immediately pre-incubated for 15 min with 5-10 µl of 0.48 U/ml bSMase dissolved in liposomes buffer or 
liposomes buffer, then further incubated for 15 min at 37°C with 5-10 µl of 5 µg/ml uncoated HAdV-C5-
EGFP or VI-L40Q.  All incubations were carried in a transparent round bottom 96-well plate (Greiner Bio-
One) containing 50 µl of liposomes buffer, in a M200 Infinite Plate Reader pre-warmed to 37°C (Tecan). 
100% liposomes leakage was determined by adding  Triton X-100 to a final concentration of 0.5%. 
Fluorescence was measured at 485 nm excitation/530 nm emission wavelength. The percentage leakage 
was calculated using the formula: 100 -[(Fmeas _ F0)/(Ftx100 _ F0)], where Fmeas is the maximum 
fluorescence intensity measured, F0 is fluorescence intensity before adding viral proteins, and Ftx100 is the 
fluorescence intensity in the presence of 0.5% Triton X-100, as described in (Wiethoff et al., 2005). 
ASMase activity: activity of ASMase was determined as described in (van Diggelen et al., 2005).  For 
extracellular ASMase activity, 1x106 cells were grown overnight in 6-cm plates. The next day, cells were 
exposed to cold binding with the indicated ligands in RPMI-0.2% FAF BSA (cholera toxin subunit B; CTB; 
Crucell;  CARexFC (Ebbinghaus et al., 2001); 1 mg/ml; kindly provided by S. Hemmi, University of Zürich). 
Unbound ligands were removed and cells placed at 37°C in 600 µl exocytosis buffer (25 mM Hepes, 125mM 
NaCl, 5 mM KCl, 1.2 mM MgSO4, 1 mM CaCl2, 1.2 mM KH2PO4, 6 mM D-glucose) for 5, 15 or 45 min. For 
calcium- and magnesium-free media, exocytosis buffer devoid of CaCl2 and MgSO4 were used for the 
washing steps after cold binding (ice cold) and for the incubation at 37°C (pre-warmed). Supernatants were 
collected and cleared by centrifugation at 11’000 g for 5 min. For total ASMase activity, lysates of cells 
treated with drugs and siRNA were re-suspended in 1 mM PMSF (Sigma) in ddH2O and the protein 
concentration was determined using the Micro BCA kit (Thermo Scientifics). Lysates were diluted to a final 
concentration of 1 µg/µl. 10 µl of cell lysates in a 96-well plate (transparent, round bottom; Greiner Bio-
One) or 300 µl of the supernatants (in eppendorf tubes) were incubated with 20 µl or 80 µl respectively of  
0.4 mg/ml 6-hexadecanoylamino-4-methylumbelliferylphosphorylcholine (HMU-PC; Moscerdam 
Substrates) in substrate buffer (0.1 M sodium acetate buffer, 0.2% (w/v), synthetic sodium taurocholate 
(Sigma), pH 5.2) for 3h at 37°C. The reaction was blocked by adding 200 µl stop buffer (0.5 M sodium 
carbonate buffer, 0.25% Triton X-100, pH 10.7) for 15 min at RT in the dark. Fluorescence was recorded 
with M200 Infinite Plate Reader (Tecan) at 404 nm excitation/460 nm emission wavelength.  
β-hexosaminidase: 
Supernatants were collected as described in the previous section (ASMase activity) and processed as 
described in (Rodríguez et al., 1997). 350 µl samples were incubated with 50 µl of 6 mM 4-methyl-
umbellyferyl-N-acetylb-d-glucosaminide (Sigma) in sodium citrate-phosphate buffer (prepared by mixing 
557.5 ml of 0.2 M Na2HPO4 with 442.5 ml of 0.1 M citric acid, and adjusting the pH to 4.5) for 1 h at 37°C. 
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The reaction was stopped by adding 100 µl of stop buffer 2 (2 M Na2CO3, 1.1 M glycine). Samples were 
gently shaked for 15 min at RT in the dark. Fluorescence was recorded with M200 Infinite Plate Reader 
(Tecan) at 404 nm excitation/460 nm emission wavelength.  
 
Lactate dehydrogenase activity: 
Supernatants were collected as described in the previous section (ASMase activity) and processed as 
described in (Rodríguez et al., 1997). 300 µl of freshly prepared, ice cold substrate (0.23 mM NADH, 1 mM 
sodium pyruvate, 0.1% Triton X-100, 0.2 M Tris-HCl (all Sigma), pH 7.3) were added to a 96-well plate 
(transparent, round bottom; Greiner Bio-One) on ice. Triton-X treated samples were diluted 1:10. 30 µl of 
supernatant was mixed with the substrate and the plate placed at 37°C in the M200 Infinite Plate Reader 
(Tecan).  A time course of NADH conversion into NAD+ by LDH was immediately started by measuring the 
decrease in absorbance at 340 nm every 2 min.  
 
Live imaging of calcium sensing and propidium iodide influx: 0.5x106 HeLa Ohio cells were transfected 
with 6 µg of either pCMV_GCamP5G (Addgene) (Akerboom et al., 2012) or Dyn2K44A-GFP (Gastaldelli et 
al., 2008) using Neon technology (100 µl tip, 1005 V, 35 ms, 2 pulses; Life Technologies). Cells were grown 
in 96-well imaging plates (Greiner Bio-one) for 24h. Cells were exposed to 1-10 µg/ml HAdV-C2-Atto565 or 
1-10 µg/ml HAdV-C2 in presence of 0.2 mg/ml propidium iodide (Molecular Probes) or absence of calcium 
where indicated. Imaging was performed between 0 and 15 min infection at 37°C with a Leica Sp5 confocal 
microscope equipped with 40× objective (oil immersion, numerical aperture 1.25). Z-stacks composed of 4x 
0.5 μm steps were recorded at a frequency of 8000 Hz applying bidirectional scan, line averaging 32x and 
minimized acquisition time. Total fluorescence intensity per cell or per indicated area was quantified with 
MacBiophotonics ImageJ (McMaster University). 
 
Flow cytometry: sub-confluent cells were harvested in PBS-20 mM EDTA and washed 2 times in cell 
medium to fully remove EDTA. 75'000 cells were incubated with 2 µg HAdV-C2/5, VI-L40Q, heat-treated 
HAdV-C2/5, HAdV-C5-Atto488 and anti-CAR antibody for 1h at 4°C, in a total volume of 100 µl. For PI 
accessibility, cells were placed 5 min at 37°C in RPMI-0.2% FAF BSA containing 0.2 mg/ml PI. For surface 
profiling, unbound antibodies or viruses were washed away and cells were fixed and stained with anti CAR 
antibody E1-1 (kindly provided by S. Hemmi, University of Zürich). For VI immunodepletion, 2 µg  heat 
treated viruses were incubated for 1h with 12 µg of either anti-VI IgG (Burckhardt et al., 2011) or an anti-
VIII IgG control (D. Püntener, unpublished) before incubation with cells for 20 min at 37°C in presence of 0.2 
mg/ml PI. Samples were analyzed with FACSCanto II (BD Biosciences).  5'000 cells per sample were 
analyzed, with FSC=319 V, SSC=33 V and PE=260 V. 
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Lysotracker signal quantification: HeLa Ohio cells were loaded with LysoTracker Red DND99 (Invitrogen) as 
indicated by the manufacturer. Time-lapse imaging of infection was performed as described above, except 
that Z-stacks were composed of 11x 0.5 µM steps and were acquired at 0 min and 20 min post-infection. 
The total lysotracker signal on maximal projections was quantified using MacBiophotonics ImageJ. The ratio 
lysotracker signal at 20 min/0 min per cell is plotted. 
 
Resazurin assay: cell toxicity was evaluated using the resazurin fluorometric assay (Czekanska, 2011). 
Briefly, after 24h of drug treatment, cells were placed into sterile filtered 0.002% resazurin (Sigma) in PBS 
for 1h and 30 min in a 37°C, 5% CO2 incubator. The reduction of resazurin to the fluorescent resorufin by 
several mitochondrial enzymes was measured using  M200 Infinite Plate Reader (Tecan) at excitation 550/9 
nm and emission 590/20 nm wavelength. 
 
Statistical analysis: statistical analysis were performed using GraphPad Prism software (GraphPad 
Software, Inc. La Jolla). Population analysis are plotted as bars or symbols and single-cell based analysis are 
represented as scatter dot plot, where the horizontal bar indicates the mean value and the vertical bars 
show the standard error of the mean. Two-tailed P-values were calculated by unpaired t-test with 
confidence interval 95%.  
 
CONCLUDING REMARKS 
 
With this study, we propose a mechanism for how incoming HAdV, a non-enveloped virus, tunes cellular 
sphingolipids for efficient invasion.  
In recent years, it became increasingly clear that cellular lipids play fundamental roles at different stages of 
the viral life cycle. Viruses have evolved various mechanisms to hijack lipid signaling, metabolism and 
synthesis for own purposes. Much about these strategies remains to be characterized, both during the host 
cell-virus interaction, and also at the physiological level. The great technical advances in the field of lipid 
research provided many valuable tools to study lipid regulations and importantly contributed to our basic 
understanding of viral infections. Moreover, gaining  further  insights into how host lipid remodeling occurs 
might offer new perspectives for anti-viral treatments. 
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ABBREVIATIONS 
 
aa  amino acids  
AFM  atomic force microscopy 
AMPs   antimicrobial peptides 
ASMase human acid sphingomyelinase 
Aβ   amyloid beta 
bSMase bacterial sphingomyelinase 
C1PP  ceramide-1-phosphate phosphatase 
CAR  coxsackievirus B and adenovirus receptor 
CDase  ceramidase 
cer   ceramide 
CERT  ceramide transfer proteins 
CHMP  charged multivesicular body protein 
CK  ceramide kinase 
CPPs   cell penetrating peptides 
CRS  cerebrosidase 
 CS  ceramide synthase 
CVB   Coxsackie virus B  
DAF   decay-accelerating factor 
DAG   diacylglycerol 
DES  dihydroceramidedesaturase 
DOPC  1,2-Dioleoyl-sn-glycero-3-phosphocholine 
EM  electron microscopy 
ESCRT  endosomal sorting complexes required for transport 
FHV  flock house virus 
GCS  glucosylceramide synthase 
GPI-PLAP GPI-anchored placental alkaline phosphatase 
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HAdV  human adenovirus 
HCV  Hepatitis C virus 
HIV TAT HIV trans-activating protein 
IAPP    islet amyloid polypeptide 
IFN  interferon 
IL  interleukin 
Ins3P  inositol 1,4,5-trisphosphate 
ISVPs  intermediate subviral particles 
JEV  japanese encephalitic virus 
LDH  lactate dehydrogenase 
MVM  minute virus of mice 
NBD-DPPE  7-nitrobenz-2-oxa-1,3-diazol-4-yl - 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine 
NPD  Niemann-Pick disease 
PC  phosphatidylcholine 
PIP2  PI(4,5)P2 , phosphatidylinositol 4,5-bisphosphate 
PLA2  phospholipase A2  
PLC  phospholipase C 
PM   plasma membrane 
POPC  1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
ROS  reactive oxygen species 
S1P  sphingosine-1-phosphate  
S1PP  S1P phosphatase 
SLO  streptolysin-O 
SM  sphingomyelin 
SMase  sphingomyelinase 
SMS   sphingomyelin synthase 
 SPT   serine-palmitoyltransferase 
syt  synaptotagmin 
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TIRFM   total internal reflection fluorescence microscopy 
TLC  thin layer chromatography 
TNF  tumor necrosis factor 
t-PnA  trans-parinaric acid 
TR-DHPE Texas Red-1,2-dihexadecanoyl-sn-glycero-3-phophoethanolamine 
VP   viral protein 
β-hex  β-hexosaminidase 
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